ONTOLOGY REPORT - ANNOTATIONS
|
||||||||||
hydrogen peroxide
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | Aass | aminoadipate-semialdehyde synthase |
|
affects expression | ISO | 4 | 49,479,938 | 49,539,782 | RGD:6480464 | CTD | |
| G | Abcb1b | ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
increases expression | EXP | 4 | 21,829,489 | 21,912,239 | RGD:6480464 | CTD | |
| G | Abhd11 | abhydrolase domain containing 11 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Acot11 | acyl-CoA thioesterase 11 |
|
affects expression | ISO | 5 | 127,820,932 | 127,870,633 | RGD:6480464 | CTD | |
| G | Acta1 | actin, alpha 1, skeletal muscle |
|
affects expression | ISO | 19 | 54,081,496 | 54,084,508 | RGD:6480464 | CTD | |
| G | Actb | actin, beta |
|
decreases expression | ISO | 12 | 12,047,070 | 12,050,040 | RGD:6480464 | CTD | |
| G | Actl7a | actin-like 7a |
|
affects expression | ISO | 5 | 74,649,956 | 74,651,431 | RGD:6480464 | CTD | |
| G | Actr3 | ARP3 actin-related protein 3 homolog (yeast) |
|
affects expression | ISO | 13 | 37,861,558 | 37,904,589 | RGD:6480464 | CTD | |
| G | Actr5 | ARP5 actin-related protein 5 homolog (yeast) |
|
affects expression | ISO | 3 | 149,357,984 | 149,371,469 | RGD:6480464 | CTD | |
| G | Actr6 | ARP6 actin-related protein 6 homolog (yeast) |
|
affects expression | ISO | 7 | 26,516,478 | 26,537,032 | RGD:6480464 | CTD | |
| G | Acyp1 | acylphosphatase 1, erythrocyte (common) type |
|
affects expression | ISO | 6 | 109,320,444 | 109,327,303 | RGD:6480464 | CTD | |
| G | Adam9 | ADAM metallopeptidase domain 9 |
|
multiple interactions | ISO | 16 | 71,446,498 | 71,526,108 | RGD:6480464 | CTD | |
| G | Adam9 | ADAM metallopeptidase domain 9 |
|
multiple interactions | ISO | 16 | 71,446,498 | 71,526,108 | RGD:6480464 | CTD | |
| G | Adam9 | ADAM metallopeptidase domain 9 |
|
increases expression | ISO | 16 | 71,446,498 | 71,526,108 | RGD:6480464 | CTD | |
| G | Adamts10 | ADAM metallopeptidase with thrombospondin type 1 motif, 10 |
|
decreases expression | ISO | 7 | 16,043,150 | 16,059,666 | RGD:6480464 | CTD | |
| G | Adamts19 | ADAM metallopeptidase with thrombospondin type 1 motif, 19 |
|
affects expression | ISO | 18 | 54,660,288 | 54,847,297 | RGD:6480464 | CTD | |
| G | Adck1 | aarF domain containing kinase 1 |
|
affects expression | ISO | 6 | 111,872,315 | 111,992,613 | RGD:6480464 | CTD | |
| G | Adck5 | aarF domain containing kinase 5 |
|
affects expression | ISO | 7 | 114,630,171 | 114,647,984 | RGD:6480464 | CTD | |
| G | Adcy3 | adenylate cyclase 3 |
|
decreases expression | ISO | 6 | 27,118,325 | 27,202,275 | RGD:6480464 | CTD | |
| G | Adh5 | alcohol dehydrogenase 5 (class III), chi polypeptide |
|
affects expression | ISO | 2 | 235,979,108 | 235,991,515 | RGD:6480464 | CTD | |
| G | Adh7 | alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
|
increases expression | ISO | 2 | 235,749,346 | 235,765,063 | RGD:6480464 | CTD | |
| G | Adi1 | acireductone dioxygenase 1 |
|
affects expression | ISO | 6 | 46,552,589 | 46,559,551 | RGD:6480464 | CTD | |
| G | Adm | adrenomedullin |
|
affects expression | ISO | 1 | 168,380,255 | 168,382,426 | RGD:6480464 | CTD | |
| G | Adm | adrenomedullin |
|
increases expression | ISO | 1 | 168,380,255 | 168,382,426 | RGD:6480464 | CTD | |
| G | Adora1 | adenosine A1 receptor |
|
decreases expression | ISO | 13 | 47,160,292 | 47,192,804 | RGD:6480464 | CTD | |
| G | Adpn | adiponutrin | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Adss | adenylosuccinate synthase |
|
affects expression | ISO | 13 | 93,681,036 | 93,711,373 | RGD:6480464 | CTD | |
| G | Adssl1 | adenylosuccinate synthase like 1 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Aff1 | AF4/FMR2 family, member 1 |
|
affects expression | ISO | 14 | 7,015,191 | 7,114,671 | RGD:6480464 | CTD | |
| G | Aftph | aftiphilin |
|
affects expression | ISO | 14 | 101,482,829 | 101,536,786 | RGD:6480464 | CTD | |
| G | Agfg2 | ArfGAP with FG repeats 2 |
|
affects expression | ISO | 12 | 19,716,015 | 19,752,171 | RGD:6480464 | CTD | |
| G | Agr2 | anterior gradient 2 homolog (Xenopus laevis) |
|
affects expression | ISO | 6 | 54,695,633 | 54,716,858 | RGD:6480464 | CTD | |
| G | Agr3 | anterior gradient 3 homolog (Xenopus laevis) |
|
affects expression | ISO | 6 | 54,629,032 | 54,652,276 | RGD:6480464 | CTD | |
| G | Agt | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases abundance | ISO | 19 | 54,738,556 | 54,750,349 | RGD:6480464 | CTD | |
| G | Agt | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions | EXP | 19 | 54,738,556 | 54,750,349 | RGD:6480464 | CTD | |
| G | Agt | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases abundance | EXP | 19 | 54,738,556 | 54,750,349 | RGD:6480464 | CTD | |
| G | Agt | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
affects expression | ISO | 19 | 54,738,556 | 54,750,349 | RGD:6480464 | CTD | |
| G | Agt | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression | EXP | 19 | 54,738,556 | 54,750,349 | RGD:6480464 | CTD | |
| G | Agt | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions | EXP | 19 | 54,738,556 | 54,750,349 | RGD:6480464 | CTD | |
| G | Agxt2l2 | alanine-glyoxylate aminotransferase 2-like 2 |
|
affects expression | ISO | 10 | 37,100,238 | 37,117,744 | RGD:6480464 | CTD | |
| G | Ahr | aryl hydrocarbon receptor |
|
affects expression | ISO | 6 | 54,205,104 | 54,240,268 | RGD:6480464 | CTD | |
| G | Ahr | aryl hydrocarbon receptor |
|
multiple interactions | ISO | 6 | 54,205,104 | 54,240,268 | RGD:6480464 | CTD | |
| G | Ahr | aryl hydrocarbon receptor |
|
decreases expression | ISO | 6 | 54,205,104 | 54,240,268 | RGD:6480464 | CTD | |
| G | Aifm2 | apoptosis-inducing factor, mitochondrion-associated 2 |
|
multiple interactions | EXP | 20 | 29,089,730 | 29,104,084 | RGD:6480464 | CTD | |
| G | Aifm2 | apoptosis-inducing factor, mitochondrion-associated 2 |
|
increases secretion | EXP | 20 | 29,089,730 | 29,104,084 | RGD:6480464 | CTD | |
| G | Aim1 | absent in melanoma 1 |
|
affects expression | ISO | 20 | 47,861,952 | 47,926,975 | RGD:6480464 | CTD | |
| G | Aimp1 | aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
|
affects expression | ISO | 2 | 230,142,679 | 230,166,226 | RGD:6480464 | CTD | |
| G | Akap7 | A kinase (PRKA) anchor protein 7 |
|
affects expression | ISO | 1 | 20,573,215 | 20,704,564 | RGD:6480464 | CTD | |
| G | Akr1c1 | aldo-keto reductase family 1, member C1 |
|
increases expression | ISO | 17 | 77,084,306 | 77,112,994 | RGD:6480464 | CTD | |
| G | Akr1c2 | aldo-keto reductase family 1, member C2 |
|
increases expression | ISO | 17 | 77,034,737 | 77,081,406 | RGD:6480464 | CTD | |
| G | Akt1 | v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions | ISO | 6 | 137,640,482 | 137,657,552 | RGD:6480464 | CTD | |
| G | Akt1 | v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions | ISO | 6 | 137,640,482 | 137,657,552 | RGD:6480464 | CTD | |
| G | Akt1 | v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation | ISO | 6 | 137,640,482 | 137,657,552 | RGD:6480464 | CTD | |
| G | Akt1 | v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions | ISO | 6 | 137,640,482 | 137,657,552 | RGD:6480464 | CTD | |
| G | Akt1 | v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions | ISO | 6 | 137,640,482 | 137,657,552 | RGD:6480464 | CTD | |
| G | Akt1 | v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation | ISO | 6 | 137,640,482 | 137,657,552 | RGD:6480464 | CTD | |
| G | Akt1 | v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions | EXP | 6 | 137,640,482 | 137,657,552 | RGD:6480464 | CTD | |
| G | Akt1 | v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation | EXP | 6 | 137,640,482 | 137,657,552 | RGD:6480464 | CTD | |
| G | Akt1 | v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions | EXP | 6 | 137,640,482 | 137,657,552 | RGD:6480464 | CTD | |
| G | Alad | aminolevulinate dehydratase |
|
affects expression | ISO | 5 | 79,505,645 | 79,515,983 | RGD:6480464 | CTD | |
| G | Alb | albumin |
|
multiple interactions | ISO | 14 | 19,126,935 | 19,142,214 | RGD:6480464 | CTD | |
| G | Alb | albumin |
|
increases abundance | ISO | 14 | 19,126,935 | 19,142,214 | RGD:6480464 | CTD | |
| G | Alb | albumin |
|
affects expression | ISO | 14 | 19,126,935 | 19,142,214 | RGD:6480464 | CTD | |
| G | Aldh1a1 | aldehyde dehydrogenase 1 family, member A1 |
|
affects expression | ISO | 1 | 223,731,675 | 223,773,285 | RGD:6480464 | CTD | |
| G | Aldh1b1 | aldehyde dehydrogenase 1 family, member B1 |
|
affects expression | ISO | 5 | 62,311,268 | 62,316,276 | RGD:6480464 | CTD | |
| G | Aldh6a1 | aldehyde dehydrogenase 6 family, member A1 |
|
affects expression | ISO | 6 | 108,495,781 | 108,516,414 | RGD:6480464 | CTD | |
| G | Alg13 | asparagine-linked glycosylation 13 |
|
affects expression | ISO | X | 34,184,163 | 34,192,061 | RGD:6480464 | CTD | |
| G | Alg5 | ALG5, dolichyl-phosphate beta-glucosyltransferase |
|
affects expression | ISO | 2 | 143,962,038 | 143,975,765 | RGD:6480464 | CTD | |
| G | Alk | anaplastic lymphoma receptor tyrosine kinase |
|
increases phosphorylation | ISO | 6 | 23,009,061 | 23,730,939 | RGD:6480464 | CTD | |
| G | Alms1 | Alstrom syndrome 1 |
|
affects expression | ISO | 4 | 119,846,037 | 119,946,085 | RGD:6480464 | CTD | |
| G | Alox5 | arachidonate 5-lipoxygenase |
|
multiple interactions | ISO | 4 | 152,610,283 | 152,657,891 | RGD:6480464 | CTD | |
| G | Alox5 | arachidonate 5-lipoxygenase |
|
increases activity | ISO | 4 | 152,610,283 | 152,657,891 | RGD:6480464 | CTD | |
| G | Alox5 | arachidonate 5-lipoxygenase |
|
multiple interactions | ISO | 4 | 152,610,283 | 152,657,891 | RGD:6480464 | CTD | |
| G | Alox5 | arachidonate 5-lipoxygenase |
|
multiple interactions | EXP | 4 | 152,610,283 | 152,657,891 | RGD:6480464 | CTD | |
| G | Alox5 | arachidonate 5-lipoxygenase |
|
affects localization | EXP | 4 | 152,610,283 | 152,657,891 | RGD:6480464 | CTD | |
| G | Alox5 | arachidonate 5-lipoxygenase |
|
multiple interactions | EXP | 4 | 152,610,283 | 152,657,891 | RGD:6480464 | CTD | |
| G | Alox5 | arachidonate 5-lipoxygenase |
|
decreases activity | EXP | 4 | 152,610,283 | 152,657,891 | RGD:6480464 | CTD | |
| G | Alox5ap | arachidonate 5-lipoxygenase activating protein |
|
increases expression | ISO | 12 | 6,245,808 | 6,269,796 | RGD:6480464 | CTD | |
| G | Als2cr8 | amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8 |
|
affects expression | ISO | 9 | 58,642,178 | 58,689,313 | RGD:6480464 | CTD | |
| G | Amd1 | adenosylmethionine decarboxylase 1 |
|
affects expression | ISO | 20 | 44,452,475 | 44,468,111 | RGD:6480464 | CTD | |
| G | Amica1 | adhesion molecule, interacts with CXADR antigen 1 |
|
affects expression | ISO | 8 | 48,034,107 | 48,058,837 | RGD:6480464 | CTD | |
| G | Amotl2 | angiomotin like 2 |
|
affects expression | ISO | 8 | 107,694,405 | 107,709,841 | RGD:6480464 | CTD | |
| G | Amph | amphiphysin |
|
decreases expression | ISO | 17 | 53,558,804 | 53,802,936 | RGD:6480464 | CTD | |
| G | Angpt1 | angiopoietin 1 |
|
affects expression | ISO | 7 | 78,195,504 | 78,451,471 | RGD:6480464 | CTD | |
| G | Ankrd1 | ankyrin repeat domain 1 |
|
affects expression | ISO | 1 | 240,316,123 | 240,324,804 | RGD:6480464 | CTD | |
| G | Ankrd16 | ankyrin repeat domain 16 |
|
affects expression | ISO | 17 | 77,930,658 | 77,943,867 | RGD:6480464 | CTD | |
| G | Anln | anillin, actin binding protein |
|
affects expression | ISO | 8 | 21,642,021 | 21,721,815 | RGD:6480464 | CTD | |
| G | Anlnl1 | anillin, actin binding protein-like 1 |
|
affects expression | ISO | 17 | 68,547,371 | 68,559,629 | RGD:6480464 | CTD | |
| G | Anxa13 | annexin A13 |
|
affects expression | ISO | 7 | 95,071,045 | 95,123,201 | RGD:6480464 | CTD | |
| G | Anxa4 | annexin A4 |
|
affects expression | ISO | 4 | 120,889,617 | 120,947,662 | RGD:6480464 | CTD | |
| G | Apc | adenomatous polyposis coli |
|
decreases expression | ISO | 18 | 26,732,147 | 26,790,383 | RGD:6480464 | CTD | |
| G | Apeh | N-acylaminoacyl-peptide hydrolase |
|
decreases response to substance | ISO | 8 | 113,353,151 | 113,362,263 | RGD:6480464 | CTD | |
| G | Apex1 | APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
increases response to substance | ISO | 15 | 26,904,124 | 26,906,224 | RGD:6480464 | CTD | |
| G | Aph1b | anterior pharynx defective 1 homolog B (C. elegans) |
|
affects expression | ISO | 8 | 71,122,681 | 71,143,726 | RGD:6480464 | CTD | |
| G | Apoa4 | apolipoprotein A-IV |
|
affects expression | ISO | 8 | 49,233,142 | 49,233,431 | RGD:6480464 | CTD | |
| G | Apob | apolipoprotein B |
|
affects expression | ISO | 6 | 31,508,060 | 31,548,083 | RGD:6480464 | CTD | |
| G | Apobec2 | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 |
|
affects expression | ISO | 9 | 7,947,500 | 7,961,013 | RGD:6480464 | CTD | |
| G | Apoc3 | apolipoprotein C-III | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Apom | apolipoprotein M |
|
affects expression | ISO | 20 | 3,754,604 | 3,757,204 | RGD:6480464 | CTD | |
| G | App | amyloid beta (A4) precursor protein |
|
multiple interactions | ISO | 11 | 24,457,855 | 24,693,851 | RGD:6480464 | CTD | |
| G | App | amyloid beta (A4) precursor protein |
|
increases expression | ISO | 11 | 24,457,855 | 24,693,851 | RGD:6480464 | CTD | |
| G | Aqp1 | aquaporin 1 |
|
affects expression | ISO | 4 | 84,098,346 | 84,110,524 | RGD:6480464 | CTD | |
| G | Aqp11 | aquaporin 11 |
|
affects expression | ISO | 1 | 154,973,796 | 154,983,962 | RGD:6480464 | CTD | |
| G | Arap3 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
|
decreases secretion | ISO | 18 | 30,893,720 | 30,916,965 | RGD:6480464 | CTD | |
| G | Areg | amphiregulin |
|
affects expression | ISO | 14 | 18,466,313 | 18,475,571 | RGD:6480464 | CTD | |
| G | Areg | amphiregulin |
|
increases expression | ISO | 14 | 18,466,313 | 18,475,571 | RGD:6480464 | CTD | |
| G | Arg1 | arginase, liver |
|
affects expression | ISO | 1 | 20,998,894 | 21,011,275 | RGD:6480464 | CTD | |
| G | Arhgap22 | Rho GTPase activating protein 22 |
|
affects expression | ISO | 16 | 8,863,537 | 8,913,459 | RGD:6480464 | CTD | |
| G | Arhgap29 | Rho GTPase activating protein 29 |
|
affects expression | ISO | 2 | 218,619,428 | 218,679,087 | RGD:6480464 | CTD | |
| G | Arhgdia | Rho GDP dissociation inhibitor (GDI) alpha |
|
decreases expression | ISO | 10 | 109,967,771 | 109,971,260 | RGD:6480464 | CTD | |
| G | Arhgef17 | Rho guanine nucleotide exchange factor (GEF) 17 |
|
affects expression | ISO | 1 | 158,316,868 | 158,375,737 | RGD:6480464 | CTD | |
| G | Arl4c | ADP-ribosylation factor-like 4C |
|
affects expression | ISO | 9 | 87,617,584 | 87,663,028 | RGD:6480464 | CTD | |
| G | Arl6ip5 | ADP-ribosylation-like factor 6 interacting protein 5 |
|
multiple interactions | ISO | 4 | 131,929,503 | 131,953,033 | RGD:6480464 | CTD | |
| G | Arl8b | ADP-ribosylation factor-like 8B |
|
affects expression | ISO | 4 | 144,299,366 | 144,344,431 | RGD:6480464 | CTD | |
| G | Armcx3 | armadillo repeat containing, X-linked 3 |
|
affects expression | ISO | X | 122,217,524 | 122,221,077 | RGD:6480464 | CTD | |
| G | Arnt | aryl hydrocarbon receptor nuclear translocator |
|
multiple interactions | ISO | 2 | 190,333,978 | 190,391,015 | RGD:6480464 | CTD | |
| G | Arnt | aryl hydrocarbon receptor nuclear translocator |
|
increases expression | ISO | 2 | 190,333,978 | 190,391,015 | RGD:6480464 | CTD | |
| G | Arnt | aryl hydrocarbon receptor nuclear translocator |
|
decreases expression | ISO | 2 | 190,333,978 | 190,391,015 | RGD:6480464 | CTD | |
| G | Astn2 | astrotactin 2 |
|
affects expression | ISO | 5 | 82,124,461 | 83,128,927 | RGD:6480464 | CTD | |
| G | Atp2a2 | ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
decreases expression | EXP | 12 | 35,266,600 | 35,316,237 | RGD:6480464 | CTD | |
| G | Atp5b | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
|
affects expression | ISO | 7 | 1,376,552 | 1,383,228 | RGD:6480464 | CTD | |
| G | Atp5f1 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 |
|
affects expression | ISO | 2 | 201,195,390 | 201,206,585 | RGD:6480464 | CTD | |
| G | Atp6v1d | ATPase, H+ transporting, lysosomal V1 subunit D |
|
affects expression | ISO | 6 | 101,479,417 | 101,494,826 | RGD:6480464 | CTD | |
| G | Atp7b | ATPase, Cu++ transporting, beta polypeptide |
|
affects expression | ISO | 16 | 74,607,988 | 74,680,080 | RGD:6480464 | CTD | |
| G | Atp8b3 | ATPase, aminophospholipid transporter, class I, type 8B, member 3 |
|
affects expression | ISO | 7 | 10,685,983 | 10,705,570 | RGD:6480464 | CTD | |
| G | Atxn1 | ataxin 1 |
|
multiple interactions | ISO | 17 | 24,719,383 | 25,138,270 | RGD:6480464 | CTD | |
| G | Atxn1 | ataxin 1 |
|
affects localization | ISO | 17 | 24,719,383 | 25,138,270 | RGD:6480464 | CTD | |
| G | Aurkb | aurora kinase B |
|
decreases expression | ISO | 10 | 55,798,710 | 55,804,367 | RGD:6480464 | CTD | |
| G | Avl9 | AVL9 homolog (S. cerevisiase) |
|
increases expression | ISO | 4 | 85,667,611 | 85,707,440 | RGD:6480464 | CTD | |
| G | Axl | Axl receptor tyrosine kinase |
|
multiple interactions | ISO | 1 | 80,964,751 | 80,994,300 | RGD:6480464 | CTD | |
| G | Axl | Axl receptor tyrosine kinase |
|
multiple interactions | EXP | 1 | 80,964,751 | 80,994,300 | RGD:6480464 | CTD | |
| G | Axl | Axl receptor tyrosine kinase |
|
increases phosphorylation | EXP | 1 | 80,964,751 | 80,994,300 | RGD:6480464 | CTD | |
| G | B3gnt3 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
|
affects expression | ISO | 16 | 18,892,320 | 18,901,908 | RGD:6480464 | CTD | |
| G | B3gnt5 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
|
affects expression | ISO | 11 | 83,396,028 | 83,408,584 | RGD:6480464 | CTD | |
| G | Bad | BCL2-associated agonist of cell death |
|
increases expression | EXP | 1 | 209,617,373 | 209,626,292 | RGD:6480464 | CTD | |
| G | Bag2 | Bcl2-associated athanogene 2 |
|
affects expression | ISO | 9 | 32,491,167 | 32,493,678 | RGD:6480464 | CTD | |
| G | Bahcc1 | BAH domain and coiled-coil containing 1 |
|
affects expression | ISO | 10 | 109,726,243 | 109,735,724 | RGD:6480464 | CTD | |
| G | Bak1 | BCL2-antagonist/killer 1 |
|
decreases expression | ISO | 20 | 5,255,954 | 5,264,593 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
decreases expression | ISO | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
multiple interactions | ISO | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
multiple interactions | ISO | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
increases activity | ISO | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
increases expression | ISO | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
increases expression | ISO | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
increases expression | ISO | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
multiple interactions | ISO | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
multiple interactions | ISO | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
multiple interactions | ISO | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
affects expression | EXP | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
increases expression | EXP | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
increases expression | EXP | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
multiple interactions | EXP | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
affects expression | EXP | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
multiple interactions | EXP | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
multiple interactions | EXP | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
multiple interactions | EXP | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Baz2a | bromodomain adjacent to zinc finger domain, 2A |
|
affects expression | ISO | 7 | 1,389,681 | 1,421,170 | RGD:6480464 | CTD | |
| G | Bbc3 | Bcl-2 binding component 3 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Bcar1 | breast cancer anti-estrogen resistance 1 |
|
affects expression | ISO | 19 | 41,646,190 | 41,669,234 | RGD:6480464 | CTD | |
| G | Bckdk | branched chain ketoacid dehydrogenase kinase |
|
affects expression | ISO | 1 | 187,189,665 | 187,194,336 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
decreases response to substance | ISO | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
decreases expression | ISO | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | ISO | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
increases expression | ISO | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | ISO | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
affects response to substance | ISO | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | EXP | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
affects expression | EXP | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | EXP | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
decreases expression | EXP | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
increases expression | EXP | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | EXP | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | EXP | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | EXP | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | EXP | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2l1 | Bcl2-like 1 |
|
increases expression | EXP | 3 | 143,129,087 | 143,180,199 | RGD:6480464 | CTD | |
| G | Bcl2l1 | Bcl2-like 1 |
|
decreases response to substance | EXP | 3 | 143,129,087 | 143,180,199 | RGD:6480464 | CTD | |
| G | Bcl2l14 | Bcl2-like 14 (apoptosis facilitator) |
|
affects expression | ISO | 4 | 171,283,106 | 171,325,345 | RGD:6480464 | CTD | |
| G | Bcl3 | B-cell CLL/lymphoma 3 |
|
affects expression | ISO | 1 | 79,122,801 | 79,137,035 | RGD:6480464 | CTD | |
| G | Bcl6 | B-cell CLL/lymphoma 6 |
|
affects expression | ISO | 11 | 79,006,123 | 79,030,555 | RGD:6480464 | CTD | |
| G | Bclaf1 | BCL2-associated transcription factor 1 |
|
affects expression | ISO | 1 | 15,605,220 | 15,632,005 | RGD:6480464 | CTD | |
| G | Bcorl1 | BCL6 co-repressor-like 1 |
|
affects expression | ISO | X | 134,755,840 | 134,802,339 | RGD:6480464 | CTD | |
| G | Bdh2 | 3-hydroxybutyrate dehydrogenase, type 2 |
|
affects expression | ISO | 2 | 232,765,049 | 232,785,694 | RGD:6480464 | CTD | |
| G | Becn1 | beclin 1, autophagy related |
|
multiple interactions | ISO | 10 | 90,317,957 | 90,333,329 | RGD:6480464 | CTD | |
| G | Becn1 | beclin 1, autophagy related |
|
increases expression | ISO | 10 | 90,317,957 | 90,333,329 | RGD:6480464 | CTD | |
| G | Bfsp1 | beaded filament structural protein 1, filensin |
|
affects expression | ISO | 3 | 132,268,138 | 132,302,378 | RGD:6480464 | CTD | |
| G | Bid | BH3 interacting domain death agonist |
|
increases expression | EXP | 4 | 157,296,383 | 157,318,481 | RGD:6480464 | CTD | |
| G | Bin1 | bridging integrator 1 |
|
multiple interactions | ISO | 18 | 24,813,407 | 24,872,852 | RGD:6480464 | CTD | |
| G | Bin1 | bridging integrator 1 |
|
affects expression | ISO | 18 | 24,813,407 | 24,872,852 | RGD:6480464 | CTD | |
| G | Birc5 | baculoviral IAP repeat-containing 5 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Bles03 | basophilic leukemia expressed protein BLES03 |
|
affects expression | ISO | 1 | 208,070,686 | 208,072,940 | RGD:6480464 | CTD | |
| G | Blm | Bloom syndrome, RecQ helicase-like |
|
affects expression | ISO | 1 | 136,271,573 | 136,358,077 | RGD:6480464 | CTD | |
| G | Blnk | B-cell linker |
|
increases expression | ISO | 1 | 246,091,335 | 246,165,075 | RGD:6480464 | CTD | |
| G | Bmp4 | bone morphogenetic protein 4 |
|
decreases expression | ISO | 15 | 22,283,171 | 22,286,757 | RGD:6480464 | CTD | |
| G | Bnip3 | BCL2/adenovirus E1B interacting protein 3 |
|
affects expression | ISO | 1 | 198,683,009 | 198,700,075 | RGD:6480464 | CTD | |
| G | Bnip3 | BCL2/adenovirus E1B interacting protein 3 |
|
decreases expression | ISO | 1 | 198,683,009 | 198,700,075 | RGD:6480464 | CTD | |
| G | Bnip3l | BCL2/adenovirus E1B interacting protein 3-like |
|
affects expression | ISO | 15 | 46,516,626 | 46,539,756 | RGD:6480464 | CTD | |
| G | Bok | BCL2-related ovarian killer |
|
affects expression | ISO | 9 | 92,970,069 | 92,980,974 | RGD:6480464 | CTD | |
| G | Brca1 | breast cancer 1, early onset |
|
decreases response to substance | ISO | 10 | 90,513,630 | 90,572,676 | RGD:6480464 | CTD | |
| G | Brd8 | bromodomain containing 8 |
|
affects expression | ISO | 18 | 27,074,235 | 27,094,586 | RGD:6480464 | CTD | |
| G | Bsdc1 | BSD domain containing 1 |
|
affects expression | ISO | 5 | 148,616,870 | 148,645,102 | RGD:6480464 | CTD | |
| G | Btg2 | BTG family, member 2 |
|
affects expression | ISO | 13 | 47,026,986 | 47,030,745 | RGD:6480464 | CTD | |
| G | Btg2 | BTG family, member 2 |
|
increases expression | ISO | 13 | 47,026,986 | 47,030,745 | RGD:6480464 | CTD | |
| G | Btg2 | BTG family, member 2 |
|
increases expression | ISO | 13 | 47,026,986 | 47,030,745 | RGD:6480464 | CTD | |
| G | Btn2a2 | butyrophilin, subfamily 2, member A2 |
|
affects expression | ISO | 17 | 48,823,679 | 48,834,495 | RGD:6480464 | CTD | |
| G | C1qbp | complement component 1, q subcomponent binding protein |
|
affects expression | ISO | 10 | 57,881,783 | 57,886,434 | RGD:6480464 | CTD | |
| G | Calu | calumenin |
|
affects expression | ISO | 4 | 56,228,617 | 56,256,118 | RGD:6480464 | CTD | |
| G | Capn2 | calpain 2, (m/II) large subunit |
|
increases expression | EXP | 13 | 98,473,367 | 98,524,463 | RGD:6480464 | CTD | |
| G | Capn2 | calpain 2, (m/II) large subunit |
|
multiple interactions | EXP | 13 | 98,473,367 | 98,524,463 | RGD:6480464 | CTD | |
| G | Capns1 | calpain, small subunit 1 |
|
decreases expression | ISO | 1 | 85,519,568 | 85,525,929 | RGD:6480464 | CTD | |
| G | Capns2 | calpain, small subunit 2 |
|
affects expression | ISO | 19 | 15,193,882 | 15,194,824 | RGD:6480464 | CTD | |
| G | Card10 | caspase recruitment domain family, member 10 |
|
affects expression | ISO | 7 | 116,737,928 | 116,766,959 | RGD:6480464 | CTD | |
| G | Carhsp1 | calcium regulated heat stable protein 1 |
|
affects expression | ISO | 10 | 6,986,583 | 7,000,181 | RGD:6480464 | CTD | |
| G | Cask | calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
|
decreases expression | ISO | X | 20,910,960 | 21,250,869 | RGD:6480464 | CTD | |
| G | Casp1 | caspase 1 |
|
increases activity | ISO | 8 | 2,027,976 | 2,036,872 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
affects expression | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
increases activity | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
increases activity | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
increases cleavage | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | EXP | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | EXP | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | EXP | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | EXP | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
decreases expression | EXP | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | EXP | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
increases activity | EXP | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | EXP | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | EXP | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | EXP | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | EXP | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | EXP | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp4 | caspase 4, apoptosis-related cysteine peptidase |
|
affects expression | ISO | 8 | 2,038,626 | 2,075,722 | RGD:6480464 | CTD | |
| G | Casp6 | caspase 6 |
|
affects expression | ISO | 2 | 227,361,538 | 227,373,844 | RGD:6480464 | CTD | |
| G | Casp7 | caspase 7 |
|
increases activity | EXP | 1 | 262,689,300 | 262,721,591 | RGD:6480464 | CTD | |
| G | Casp7 | caspase 7 |
|
multiple interactions | EXP | 1 | 262,689,300 | 262,721,591 | RGD:6480464 | CTD | |
| G | Casp8 | caspase 8 |
|
increases activity | ISO | 9 | 57,389,353 | 57,437,803 | RGD:6480464 | CTD | |
| G | Casp8 | caspase 8 |
|
multiple interactions | ISO | 9 | 57,389,353 | 57,437,803 | RGD:6480464 | CTD | |
| G | Casp8 | caspase 8 |
|
multiple interactions | EXP | 9 | 57,389,353 | 57,437,803 | RGD:6480464 | CTD | |
| G | Casp8 | caspase 8 |
|
increases activity | EXP | 9 | 57,389,353 | 57,437,803 | RGD:6480464 | CTD | |
| G | Casp9 | caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 5 | 160,704,234 | 160,721,796 | RGD:6480464 | CTD | |
| G | Casp9 | caspase 9, apoptosis-related cysteine peptidase |
|
increases activity | ISO | 5 | 160,704,234 | 160,721,796 | RGD:6480464 | CTD | |
| G | Casp9 | caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 5 | 160,704,234 | 160,721,796 | RGD:6480464 | CTD | |
| G | Casp9 | caspase 9, apoptosis-related cysteine peptidase |
|
increases cleavage | ISO | 5 | 160,704,234 | 160,721,796 | RGD:6480464 | CTD | |
| G | Casp9 | caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 5 | 160,704,234 | 160,721,796 | RGD:6480464 | CTD | |
| G | Casp9 | caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions | EXP | 5 | 160,704,234 | 160,721,796 | RGD:6480464 | CTD | |
| G | Cast | calpastatin |
|
affects expression | ISO | 2 | 1,495,048 | 1,608,477 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
affects response to substance | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
multiple interactions | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
multiple interactions | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
multiple interactions | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
multiple interactions | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
multiple interactions | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
multiple interactions | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
multiple interactions | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
multiple interactions | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
decreases response to substance | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
increases activity | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
affects expression | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
increases expression | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
multiple interactions | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
increases expression | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
affects response to substance | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
multiple interactions | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
decreases activity | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
decreases expression | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
increases activity | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
increases expression | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
multiple interactions | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
multiple interactions | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
multiple interactions | EXP | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
increases activity | EXP | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
multiple interactions | EXP | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
increases expression | EXP | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
multiple interactions | EXP | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cav1 | caveolin 1, caveolae protein |
|
multiple interactions | ISO | 4 | 42,956,102 | 42,989,057 | RGD:6480464 | CTD | |
| G | Cav1 | caveolin 1, caveolae protein |
|
increases expression | ISO | 4 | 42,956,102 | 42,989,057 | RGD:6480464 | CTD | |
| G | Cav1 | caveolin 1, caveolae protein |
|
multiple interactions | ISO | 4 | 42,956,102 | 42,989,057 | RGD:6480464 | CTD | |
| G | Cav1 | caveolin 1, caveolae protein |
|
multiple interactions | ISO | 4 | 42,956,102 | 42,989,057 | RGD:6480464 | CTD | |
| G | Cav1 | caveolin 1, caveolae protein |
|
multiple interactions | ISO | 4 | 42,956,102 | 42,989,057 | RGD:6480464 | CTD | |
| G | Cav1 | caveolin 1, caveolae protein |
|
increases expression | ISO | 4 | 42,956,102 | 42,989,057 | RGD:6480464 | CTD | |
| G | Cav1 | caveolin 1, caveolae protein |
|
increases expression | ISO | 4 | 42,956,102 | 42,989,057 | RGD:6480464 | CTD | |
| G | Cav1 | caveolin 1, caveolae protein |
|
multiple interactions | ISO | 4 | 42,956,102 | 42,989,057 | RGD:6480464 | CTD | |
| G | Cav1 | caveolin 1, caveolae protein |
|
multiple interactions | ISO | 4 | 42,956,102 | 42,989,057 | RGD:6480464 | CTD | |
| G | Cbfb | core-binding factor, beta subunit |
|
affects expression | ISO | 19 | 34,985,879 | 35,029,446 | RGD:6480464 | CTD | |
| G | Cblb | Cbl proto-oncogene, E3 ubiquitin protein ligase B |
|
affects expression | ISO | 11 | 49,690,402 | 49,856,762 | RGD:6480464 | CTD | |
| G | Cbx7 | chromobox homolog 7 |
|
affects expression | ISO | 7 | 118,148,413 | 118,165,701 | RGD:6480464 | CTD | |
| G | Ccdc150 | coiled-coil domain containing 150 |
|
affects expression | ISO | 9 | 53,085,922 | 53,172,920 | RGD:6480464 | CTD | |
| G | Ccdc28a | coiled-coil domain containing 28A |
|
affects expression | ISO | 1 | 13,269,164 | 13,284,200 | RGD:6480464 | CTD | |
| G | Ccdc38 | coiled-coil domain containing 38 |
|
increases expression | ISO | 7 | 30,601,969 | 30,643,967 | RGD:6480464 | CTD | |
| G | Ccdc86 | coiled-coil domain containing 86 |
|
affects expression | ISO | 1 | 213,440,231 | 213,445,812 | RGD:6480464 | CTD | |
| G | Cck | cholecystokinin |
|
affects expression | ISO | 8 | 126,492,636 | 126,499,220 | RGD:6480464 | CTD | |
| G | Ccl2 | chemokine (C-C motif) ligand 2 |
|
increases expression | ISO | 10 | 70,256,263 | 70,258,061 | RGD:6480464 | CTD | |
| G | Ccl2 | chemokine (C-C motif) ligand 2 |
|
multiple interactions | ISO | 10 | 70,256,263 | 70,258,061 | RGD:6480464 | CTD | |
| G | Ccl2 | chemokine (C-C motif) ligand 2 |
|
increases expression | ISO | 10 | 70,256,263 | 70,258,061 | RGD:6480464 | CTD | |
| G | Ccl2 | chemokine (C-C motif) ligand 2 |
|
multiple interactions | ISO | 10 | 70,256,263 | 70,258,061 | RGD:6480464 | CTD | |
| G | Ccna1 | cyclin A1 |
|
decreases expression | ISO | 2 | 144,275,211 | 144,285,196 | RGD:6480464 | CTD | |
| G | Ccna2 | cyclin A2 |
|
decreases expression | ISO | 2 | 123,062,752 | 123,069,085 | RGD:6480464 | CTD | |
| G | Ccnb1 | cyclin B1 |
|
affects expression | ISO | 2 | 31,574,600 | 31,581,784 | RGD:6480464 | CTD | |
| G | Cd33 | CD33 molecule |
|
multiple interactions | ISO | 1 | 93,904,033 | 93,910,383 | RGD:6480464 | CTD | |
| G | Cd59 | CD59 molecule, complement regulatory protein |
|
increases mutagenesis | ISO | 3 | 89,243,600 | 89,245,129 | RGD:6480464 | CTD | |
| G | Cd59 | CD59 molecule, complement regulatory protein |
|
increases mutagenesis | ISO | 3 | 89,243,600 | 89,245,129 | RGD:6480464 | CTD | |
| G | Cd68 | Cd68 molecule |
|
increases expression | ISO | 10 | 56,481,701 | 56,483,580 | RGD:6480464 | CTD | |
| G | Cd97 | CD97 molecule |
|
affects expression | ISO | 19 | 26,089,268 | 26,108,997 | RGD:6480464 | CTD | |
| G | Cda | cytidine deaminase |
|
affects expression | ISO | 5 | 157,117,303 | 157,143,989 | RGD:6480464 | CTD | |
| G | Cdc16 | cell division cycle 16 |
|
affects expression | ISO | 16 | 80,628,131 | 80,650,925 | RGD:6480464 | CTD | |
| G | Cdc20 | cell division cycle 20 |
|
decreases expression | ISO | 5 | 138,913,180 | 138,916,744 | RGD:6480464 | CTD | |
| G | Cdc25a | cell division cycle 25A |
|
affects expression | ISO | 8 | 114,237,704 | 114,255,971 | RGD:6480464 | CTD | |
| G | Cdc25a | cell division cycle 25A |
|
decreases expression | ISO | 8 | 114,237,704 | 114,255,971 | RGD:6480464 | CTD | |
| G | Cdc25c | cell division cycle 25C |
|
affects expression | ISO | 18 | 27,206,537 | 27,225,811 | RGD:6480464 | CTD | |
| G | Cdc25c | cell division cycle 25C |
|
decreases expression | ISO | 18 | 27,206,537 | 27,225,811 | RGD:6480464 | CTD | |
| G | Cdc25c | cell division cycle 25C |
|
increases expression | ISO | 18 | 27,206,537 | 27,225,811 | RGD:6480464 | CTD | |
| G | Cdc42ep2 | CDC42 effector protein (Rho GTPase binding) 2 |
|
affects expression | ISO | 1 | 208,548,137 | 208,556,965 | RGD:6480464 | CTD | |
| G | Cdc5l | cell division cycle 5-like |
|
affects expression | ISO | 9 | 11,165,631 | 11,204,135 | RGD:6480464 | CTD | |
| G | Cdca2 | cell division cycle associated 2 |
|
affects expression | ISO | 15 | 47,225,711 | 47,271,412 | RGD:6480464 | CTD | |
| G | Cdh11 | cadherin 11 |
|
decreases expression | ISO | 19 | 2,225,209 | 2,382,805 | RGD:6480464 | CTD | |
| G | Cdh2 | cadherin 2 |
|
decreases expression | ISO | 18 | 8,048,920 | 8,267,974 | RGD:6480464 | CTD | |
| G | Cdh3 | cadherin 3 |
|
decreases expression | ISO | 19 | 36,343,823 | 36,393,819 | RGD:6480464 | CTD | |
| G | Cdk1 | cyclin-dependent kinase 1 |
|
affects expression | ISO | 20 | 20,018,044 | 20,044,030 | RGD:6480464 | CTD | |
| G | Cdk10 | cyclin-dependent kinase 10 |
|
decreases expression | ISO | 19 | 53,545,204 | 53,552,911 | RGD:6480464 | CTD | |
| G | Cdk15 | cyclin-dependent kinase 15 |
|
affects expression | ISO | 9 | 57,840,625 | 57,930,096 | RGD:6480464 | CTD | |
| G | Cdk2 | cyclin dependent kinase 2 |
|
decreases expression | ISO | 7 | 2,000,196 | 2,007,682 | RGD:6480464 | CTD | |
| G | Cdk2 | cyclin dependent kinase 2 |
|
decreases activity | ISO | 7 | 2,000,196 | 2,007,682 | RGD:6480464 | CTD | |
| G | Cdk5 | cyclin-dependent kinase 5 |
|
affects expression | ISO | 4 | 6,119,704 | 6,124,186 | RGD:6480464 | CTD | |
| G | Cdk9 | cyclin-dependent kinase 9 |
|
decreases expression | ISO | 3 | 11,672,861 | 11,677,709 | RGD:6480464 | CTD | |
| G | Cdkl3 | cyclin-dependent kinase-like 3 |
|
affects expression | ISO | 10 | 37,527,865 | 37,552,851 | RGD:6480464 | CTD | |
| G | Cdkn1a | cyclin-dependent kinase inhibitor 1A |
|
increases expression | ISO | 20 | 7,376,325 | 7,386,778 | RGD:6480464 | CTD | |
| G | Cdkn1a | cyclin-dependent kinase inhibitor 1A |
|
increases expression | ISO | 20 | 7,376,325 | 7,386,778 | RGD:6480464 | CTD | |
| G | Cdkn1a | cyclin-dependent kinase inhibitor 1A |
|
increases expression | ISO | 20 | 7,376,325 | 7,386,778 | RGD:6480464 | CTD | |
| G | Cdkn1a | cyclin-dependent kinase inhibitor 1A |
|
increases expression | ISO | 20 | 7,376,325 | 7,386,778 | RGD:6480464 | CTD | |
| G | Cdkn1a | cyclin-dependent kinase inhibitor 1A |
|
multiple interactions | ISO | 20 | 7,376,325 | 7,386,778 | RGD:6480464 | CTD | |
| G | Cdkn1a | cyclin-dependent kinase inhibitor 1A |
|
multiple interactions | ISO | 20 | 7,376,325 | 7,386,778 | RGD:6480464 | CTD | |
| G | Cdkn1a | cyclin-dependent kinase inhibitor 1A |
|
multiple interactions | ISO | 20 | 7,376,325 | 7,386,778 | RGD:6480464 | CTD | |
| G | Cdkn1a | cyclin-dependent kinase inhibitor 1A |
|
increases expression | ISO | 20 | 7,376,325 | 7,386,778 | RGD:6480464 | CTD | |
| G | Cdkn1a | cyclin-dependent kinase inhibitor 1A |
|
multiple interactions | ISO | 20 | 7,376,325 | 7,386,778 | RGD:6480464 | CTD | |
| G | Cdkn1c | cyclin-dependent kinase inhibitor 1C |
|
affects expression | ISO | 1 | 203,835,215 | 203,837,844 | RGD:6480464 | CTD | |
| G | Cdkn2b | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
decreases expression | ISO | 5 | 108,939,669 | 108,945,293 | RGD:6480464 | CTD | |
| G | Cdkn2b | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
decreases expression | ISO | 5 | 108,939,669 | 108,945,293 | RGD:6480464 | CTD | |
| G | Cdrt4 | CMT1A duplicated region transcript 4 |
|
affects expression | ISO | 10 | 49,164,392 | 49,166,416 | RGD:6480464 | CTD | |
| G | Cdx2 | caudal type homeo box 2 |
|
affects expression | ISO | 12 | 8,296,103 | 8,303,643 | RGD:6480464 | CTD | |
| G | Ceacam1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
|
affects expression | ISO | 1 | 80,742,540 | 80,758,943 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
affects expression | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpd | CCAAT/enhancer binding protein (C/EBP), delta | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Cebpg | CCAAT/enhancer binding protein (C/EBP), gamma |
|
affects expression | ISO | 1 | 87,552,695 | 87,559,447 | RGD:6480464 | CTD | |
| G | Cenpa | centromere protein A |
|
decreases expression | ISO | 6 | 25,686,603 | 25,693,840 | RGD:6480464 | CTD | |
| G | Cenpf | centromere protein F |
|
affects expression | ISO | 13 | 105,920,242 | 105,965,655 | RGD:6480464 | CTD | |
| G | Cenph | centromere protein H |
|
affects expression | ISO | 2 | 31,556,870 | 31,570,470 | RGD:6480464 | CTD | |
| G | Cep120 | centrosomal protein 120 |
|
affects expression | ISO | 18 | 49,192,432 | 49,255,022 | RGD:6480464 | CTD | |
| G | Cep89 | centrosomal protein 89kDa |
|
affects expression | ISO | 1 | 87,924,013 | 87,966,500 | RGD:6480464 | CTD | |
| G | Cetn2 | centrin, EF-hand protein, 2 |
|
affects expression | ISO | X | 158,917,650 | 158,923,210 | RGD:6480464 | CTD | |
| G | Cflar | CASP8 and FADD-like apoptosis regulator |
|
increases expression | ISO | 9 | 57,309,836 | 57,356,635 | RGD:6480464 | CTD | |
| G | Cflar | CASP8 and FADD-like apoptosis regulator |
|
decreases expression | EXP | 9 | 57,309,836 | 57,356,635 | RGD:6480464 | CTD | |
| G | Cftr | cystic fibrosis transmembrane conductance regulator |
|
affects expression | ISO | 4 | 43,874,852 | 44,041,870 | RGD:6480464 | CTD | |
| G | Cgref1 | cell growth regulator with EF hand domain 1 |
|
affects expression | ISO | 6 | 25,414,812 | 25,426,818 | RGD:6480464 | CTD | |
| G | Chd4 | chromodomain helicase DNA binding protein 4 |
|
affects expression | ISO | 4 | 161,217,964 | 161,251,018 | RGD:6480464 | CTD | |
| G | Chek1 | checkpoint kinase 1 |
|
decreases expression | ISO | 8 | 37,954,322 | 37,974,748 | RGD:6480464 | CTD | |
| G | Chsy1 | chondroitin sulfate synthase 1 |
|
affects expression | ISO | 1 | 120,539,002 | 120,600,102 | RGD:6480464 | CTD | |
| G | Cirh1a | cirrhosis, autosomal recessive 1A (cirhin) |
|
affects expression | ISO | 19 | 36,742,206 | 36,770,285 | RGD:6480464 | CTD | |
| G | Cish | cytokine inducible SH2-containing protein |
|
affects expression | ISO | 8 | 112,541,034 | 112,545,982 | RGD:6480464 | CTD | |
| G | Cited2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
affects expression | ISO | 1 | 12,721,500 | 12,723,943 | RGD:6480464 | CTD | |
| G | Ckb | creatine kinase, brain |
|
affects expression | ISO | 6 | 136,452,215 | 136,455,122 | RGD:6480464 | CTD | |
| G | Ckm | creatine kinase, muscle |
|
multiple interactions | EXP | 1 | 78,762,202 | 78,772,681 | RGD:6480464 | CTD | |
| G | Ckm | creatine kinase, muscle |
|
decreases expression | EXP | 1 | 78,762,202 | 78,772,681 | RGD:6480464 | CTD | |
| G | Clcf1 | cardiotrophin-like cytokine factor 1 |
|
affects expression | ISO | 1 | 206,802,745 | 206,806,332 | RGD:6480464 | CTD | |
| G | Cldn1 | claudin 1 |
|
affects expression | ISO | 11 | 76,473,654 | 76,488,809 | RGD:6480464 | CTD | |
| G | Cldn2 | claudin 2 |
|
affects expression | ISO | X | 127,538,685 | 127,549,019 | RGD:6480464 | CTD | |
| G | Cldn23 | claudin 23 |
|
affects expression | ISO | 16 | 60,109,161 | 60,110,885 | RGD:6480464 | CTD | |
| G | Cldn3 | claudin 3 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Cldn6 | claudin 6 |
|
multiple interactions | ISO | 10 | 12,944,503 | 12,947,271 | RGD:6480464 | CTD | |
| G | Cldn6 | claudin 6 |
|
affects expression | ISO | 10 | 12,944,503 | 12,947,271 | RGD:6480464 | CTD | |
| G | Cldn7 | claudin 7 |
|
affects expression | ISO | 10 | 56,810,947 | 56,813,134 | RGD:6480464 | CTD | |
| G | Cldn8 | claudin 8 |
|
affects expression | ISO | 11 | 28,419,612 | 28,421,861 | RGD:6480464 | CTD | |
| G | Cldn9 | claudin 9 |
|
multiple interactions | ISO | 10 | 12,947,423 | 12,948,854 | RGD:6480464 | CTD | |
| G | Cldn9 | claudin 9 |
|
affects expression | ISO | 10 | 12,947,423 | 12,948,854 | RGD:6480464 | CTD | |
| G | Cldnd1 | claudin domain containing 1 |
|
affects expression | ISO | 11 | 42,694,705 | 42,700,946 | RGD:6480464 | CTD | |
| G | Clic5 | chloride intracellular channel 5 |
|
affects expression | ISO | 9 | 12,370,341 | 12,472,969 | RGD:6480464 | CTD | |
| G | Clmp | CXADR-like membrane protein |
|
affects expression | ISO | 8 | 43,661,696 | 43,769,479 | RGD:6480464 | CTD | |
| G | Clptm1l | CLPTM1-like |
|
affects expression | ISO | 1 | 30,474,672 | 30,490,655 | RGD:6480464 | CTD | |
| G | Cmtm6 | CKLF-like MARVEL transmembrane domain containing 6 |
|
affects expression | ISO | 8 | 119,149,810 | 119,165,515 | RGD:6480464 | CTD | |
| G | Cnksr3 | Cnksr family member 3 |
|
affects expression | ISO | 1 | 37,865,904 | 37,958,862 | RGD:6480464 | CTD | |
| G | Cnnm2 | cyclin M2 |
|
affects expression | ISO | 1 | 252,077,259 | 252,195,971 | RGD:6480464 | CTD | |
| G | Cnot2 | CCR4-NOT transcription complex, subunit 2 |
|
affects expression | ISO | 7 | 55,823,982 | 55,880,812 | RGD:6480464 | CTD | |
| G | Cntf | ciliary neurotrophic factor |
|
multiple interactions | ISO | 1 | 215,842,668 | 215,844,691 | RGD:6480464 | CTD | |
| G | Cntf | ciliary neurotrophic factor |
|
decreases activity | ISO | 1 | 215,842,668 | 215,844,691 | RGD:6480464 | CTD | |
| G | Cntf | ciliary neurotrophic factor |
|
multiple interactions | ISO | 1 | 215,842,668 | 215,844,691 | RGD:6480464 | CTD | |
| G | Cog6 | component of oligomeric golgi complex 6 |
|
affects expression | ISO | 2 | 142,767,258 | 142,804,731 | RGD:6480464 | CTD | |
| G | Col16a1 | collagen, type XVI, alpha 1 |
|
affects expression | ISO | 5 | 149,072,905 | 149,126,350 | RGD:6480464 | CTD | |
| G | Col18a1 | collagen, type XVIII, alpha 1 |
|
affects expression | ISO | 20 | 11,920,816 | 11,982,468 | RGD:6480464 | CTD | |
| G | Col1a1 | collagen, type I, alpha 1 |
|
multiple interactions | ISO | 10 | 83,622,438 | 83,639,368 | RGD:6480464 | CTD | |
| G | Col9a3 | collagen, type IX, alpha 3 |
|
affects expression | ISO | 3 | 169,704,893 | 169,712,492 | RGD:6480464 | CTD | |
| G | Commd8 | COMM domain containing 8 |
|
affects expression | ISO | 14 | 38,498,899 | 38,509,474 | RGD:6480464 | CTD | |
| G | Comt | catechol-O-methyltransferase |
|
decreases expression | ISO | 11 | 84,561,591 | 84,581,713 | RGD:6480464 | CTD | |
| G | Copb2 | coatomer protein complex, subunit beta 2 (beta prime) | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Cops5 | COP9 signalosome subunit 5 |
|
affects expression | ISO | 5 | 8,709,214 | 8,727,277 | RGD:6480464 | CTD | |
| G | Cops8 | COP9 signalosome subunit 8 |
|
affects expression | ISO | 9 | 89,802,461 | 89,812,293 | RGD:6480464 | CTD | |
| G | Coq5 | coenzyme Q5 homolog, methyltransferase (S. cerevisiae) |
|
affects expression | ISO | 12 | 42,585,095 | 42,602,004 | RGD:6480464 | CTD | |
| G | Coro2a | coronin, actin binding protein 2A |
|
affects expression | ISO | 5 | 63,121,905 | 63,152,843 | RGD:6480464 | CTD | |
| G | Cox5b | cytochrome c oxidase subunit Vb |
|
multiple interactions | ISO | 9 | 35,625,478 | 35,627,304 | RGD:6480464 | CTD | |
| G | Cp | ceruloplasmin (ferroxidase) |
|
multiple interactions | ISO | 2 | 105,086,278 | 105,135,367 | RGD:6480464 | CTD | |
| G | Cp | ceruloplasmin (ferroxidase) |
|
decreases expression | ISO | 2 | 105,086,278 | 105,135,367 | RGD:6480464 | CTD | |
| G | Cp | ceruloplasmin (ferroxidase) |
|
increases degradation | ISO | 2 | 105,086,278 | 105,135,367 | RGD:6480464 | CTD | |
| G | Cp | ceruloplasmin (ferroxidase) |
|
decreases expression | ISO | 2 | 105,086,278 | 105,135,367 | RGD:6480464 | CTD | |
| G | Cpeb3 | cytoplasmic polyadenylation element binding protein 3 |
|
affects expression | ISO | 1 | 241,298,277 | 241,444,908 | RGD:6480464 | CTD | |
| G | Cps1 | carbamoyl-phosphate synthetase 1 |
|
affects expression | ISO | 9 | 65,907,211 | 66,017,942 | RGD:6480464 | CTD | |
| G | Cpsf2 | cleavage and polyadenylation specific factor 2, 100kDa |
|
affects expression | ISO | 6 | 126,246,237 | 126,274,144 | RGD:6480464 | CTD | |
| G | Creb3l3 | cAMP responsive element binding protein 3-like 3 |
|
affects expression | ISO | 7 | 10,106,525 | 10,114,960 | RGD:6480464 | CTD | |
| G | Creb3l4 | cAMP responsive element binding protein 3-like 4 |
|
affects expression | ISO | 2 | 182,477,247 | 182,482,238 | RGD:6480464 | CTD | |
| G | Crebrf | CREB3 regulatory factor |
|
affects expression | ISO | 10 | 16,665,420 | 16,723,929 | RGD:6480464 | CTD | |
| G | Crhr1 | corticotropin releasing hormone receptor 1 |
|
decreases expression | ISO | 10 | 93,312,405 | 93,354,229 | RGD:6480464 | CTD | |
| G | Crip1 | cysteine-rich protein 1 (intestinal) |
|
affects expression | ISO | 6 | 138,156,366 | 138,161,127 | RGD:6480464 | CTD | |
| G | Crsp9 | cofactor required for Sp1 transcriptional activation, subunit 9 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Cryl1 | crystallin, lambda 1 |
|
affects expression | ISO | 15 | 36,320,075 | 36,440,579 | RGD:6480464 | CTD | |
| G | Crym | crystallin, mu | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Cryz | crystallin, zeta (quinone reductase) |
|
affects expression | ISO | 2 | 252,433,559 | 252,461,038 | RGD:6480464 | CTD | |
| G | Csde1 | cold shock domain containing E1, RNA binding | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Csf1r | colony stimulating factor 1 receptor |
|
affects expression | ISO | 18 | 57,080,324 | 57,107,295 | RGD:6480464 | CTD | |
| G | Csgalnact1 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
|
affects expression | ISO | 16 | 22,852,516 | 22,947,139 | RGD:6480464 | CTD | |
| G | Csnk1g2 | casein kinase 1, gamma 2 |
|
decreases expression | ISO | 7 | 10,587,247 | 10,620,696 | RGD:6480464 | CTD | |
| G | Cux1 | cut-like homeobox 1 |
|
decreases expression | ISO | 12 | 21,223,919 | 21,516,938 | RGD:6480464 | CTD | |
| G | Cxcl12 | chemokine (C-X-C motif) ligand 12 |
|
increases expression | ISO | 4 | 153,503,576 | 153,516,423 | RGD:6480464 | CTD | |
| G | Cxcl12 | chemokine (C-X-C motif) ligand 12 |
|
multiple interactions | ISO | 4 | 153,503,576 | 153,516,423 | RGD:6480464 | CTD | |
| G | Cxcl2 | chemokine (C-X-C motif) ligand 2 |
|
affects expression | ISO | 14 | 18,677,129 | 18,679,175 | RGD:6480464 | CTD | |
| G | Cxcl2 | chemokine (C-X-C motif) ligand 2 |
|
increases expression | ISO | 14 | 18,677,129 | 18,679,175 | RGD:6480464 | CTD | |
| G | Cxcl2 | chemokine (C-X-C motif) ligand 2 |
|
multiple interactions | EXP | 14 | 18,677,129 | 18,679,175 | RGD:6480464 | CTD | |
| G | Cxcr4 | chemokine (C-X-C motif) receptor 4 |
|
affects expression | ISO | 13 | 41,308,286 | 41,312,190 | RGD:6480464 | CTD | |
| G | Cyb5a | cytochrome b5 type A (microsomal) |
|
affects expression | ISO | 18 | 81,415,972 | 81,452,606 | RGD:6480464 | CTD | |
| G | Cyb5b | cytochrome b5 type B (outer mitochondrial membrane) |
|
affects expression | ISO | 19 | 37,016,959 | 37,050,722 | RGD:6480464 | CTD | |
| G | Cyb5d2 | cytochrome b5 domain containing 2 |
|
affects expression | ISO | 10 | 59,667,011 | 59,683,247 | RGD:6480464 | CTD | |
| G | Cygb | cytoglobin |
|
increases metabolic processing | EXP | 10 | 106,759,885 | 106,769,651 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
affects expression | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression | EXP | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1b1 | cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
affects expression | ISO | 6 | 2,548,224 | 2,553,767 | RGD:6480464 | CTD | |
| G | Cyp1b1 | cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression | ISO | 6 | 2,548,224 | 2,553,767 | RGD:6480464 | CTD | |
| G | Cyp2b1 | cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
multiple interactions | EXP | 1 | 81,266,828 | 81,290,471 | RGD:6480464 | CTD | |
| G | Cyp2s1 | cytochrome P450, family 2, subfamily s, polypeptide 1 |
|
multiple interactions | ISO | 1 | 81,008,464 | 81,023,486 | RGD:6480464 | CTD | |
| G | Cyp2w1 | cytochrome P450, family 2, subfamily w, polypeptide 1 |
|
affects expression | ISO | 12 | 15,792,480 | 15,797,202 | RGD:6480464 | CTD | |
| G | Cyp3a2 | cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression | ISO | 12 | 9,517,016 | 9,541,000 | RGD:6480464 | CTD | |
| G | Cyp51 | cytochrome P450, family 51 |
|
multiple interactions | ISO | 4 | 26,752,677 | 26,771,131 | RGD:6480464 | CTD | |
| G | Cyr61 | cysteine-rich, angiogenic inducer, 61 |
|
affects expression | ISO | 2 | 243,824,303 | 243,827,262 | RGD:6480464 | CTD | |
| G | Cyr61 | cysteine-rich, angiogenic inducer, 61 |
|
increases expression | ISO | 2 | 243,824,303 | 243,827,262 | RGD:6480464 | CTD | |
| G | Cytl1 | cytokine like 1 |
|
decreases expression | ISO | 14 | 78,349,878 | 78,354,888 | RGD:6480464 | CTD | |
| G | Dapk1 | death associated protein kinase 1 |
|
affects expression | ISO | 17 | 9,617,607 | 9,779,457 | RGD:6480464 | CTD | |
| G | Dapk1 | death associated protein kinase 1 |
|
decreases expression | ISO | 17 | 9,617,607 | 9,779,457 | RGD:6480464 | CTD | |
| G | Dars | aspartyl-tRNA synthetase |
|
affects expression | ISO | 13 | 41,077,395 | 41,132,513 | RGD:6480464 | CTD | |
| G | Dcaf11 | DDB1 and CUL4 associated factor 11 |
|
affects expression | ISO | 15 | 33,691,576 | 33,701,328 | RGD:6480464 | CTD | |
| G | Dcaf13 | DDB1 and CUL4 associated factor 13 |
|
affects expression | ISO | 7 | 74,668,602 | 74,703,968 | RGD:6480464 | CTD | |
| G | Dcaf4 | DDB1 and CUL4 associated factor 4 |
|
affects expression | ISO | 6 | 107,468,810 | 107,494,910 | RGD:6480464 | CTD | |
| G | Dclre1a | DNA cross-link repair 1A |
|
affects expression | ISO | 1 | 262,822,176 | 262,840,988 | RGD:6480464 | CTD | |
| G | Dctn3 | dynactin 3 |
|
affects expression | ISO | 5 | 59,139,424 | 59,147,420 | RGD:6480464 | CTD | |
| G | Dctpp1 | dCTP pyrophosphatase 1 |
|
affects expression | ISO | 1 | 186,519,955 | 186,523,348 | RGD:6480464 | CTD | |
| G | Ddit3 | DNA-damage inducible transcript 3 |
|
affects expression | ISO | 7 | 67,247,749 | 67,252,571 | RGD:6480464 | CTD | |
| G | Ddit3 | DNA-damage inducible transcript 3 |
|
increases expression | ISO | 7 | 67,247,749 | 67,252,571 | RGD:6480464 | CTD | |
| G | Ddit3 | DNA-damage inducible transcript 3 |
|
multiple interactions | ISO | 7 | 67,247,749 | 67,252,571 | RGD:6480464 | CTD | |
| G | Ddit3 | DNA-damage inducible transcript 3 |
|
increases expression | ISO | 7 | 67,247,749 | 67,252,571 | RGD:6480464 | CTD | |
| G | Ddit4 | DNA-damage-inducible transcript 4 |
|
affects expression | ISO | 20 | 27,252,273 | 27,254,371 | RGD:6480464 | CTD | |
| G | Ddit4 | DNA-damage-inducible transcript 4 |
|
increases expression | ISO | 20 | 27,252,273 | 27,254,371 | RGD:6480464 | CTD | |
| G | Ddr2 | discoidin domain receptor tyrosine kinase 2 |
|
decreases expression | ISO | 13 | 85,801,449 | 85,846,636 | RGD:6480464 | CTD | |
| G | Ddx1 | DEAD (Asp-Glu-Ala-Asp) box helicase 1 |
|
affects expression | ISO | 6 | 36,794,602 | 36,825,473 | RGD:6480464 | CTD | |
| G | Ddx10 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 10 |
|
affects expression | ISO | 8 | 56,557,483 | 56,706,523 | RGD:6480464 | CTD | |
| G | Ddx20 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 |
|
affects expression | ISO | 2 | 200,929,985 | 200,937,976 | RGD:6480464 | CTD | |
| G | Ddx42 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 42 |
|
increases expression | ISO | 10 | 95,612,667 | 95,644,162 | RGD:6480464 | CTD | |
| G | Ddx5 | DEAD (Asp-Glu-Ala-Asp) box helicase 5 |
|
affects expression | ISO | 10 | 96,131,888 | 96,139,423 | RGD:6480464 | CTD | |
| G | Ddx50 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 50 |
|
affects expression | ISO | 20 | 29,867,955 | 29,897,253 | RGD:6480464 | CTD | |
| G | Ddx56 | DEAD (Asp-Glu-Ala-Asp) box helicase 56 |
|
affects expression | ISO | 14 | 86,985,893 | 86,994,552 | RGD:6480464 | CTD | |
| G | Def6 | differentially expressed in FDCP 6 homolog (mouse) |
|
affects expression | ISO | 20 | 6,391,694 | 6,469,830 | RGD:6480464 | CTD | |
| G | Def8 | differentially expressed in FDCP 8 homolog (mouse) |
|
affects expression | ISO | 19 | 53,765,017 | 53,781,294 | RGD:6480464 | CTD | |
| G | Defb1 | defensin beta 1 |
|
affects expression | ISO | 16 | 74,980,054 | 74,995,445 | RGD:6480464 | CTD | |
| G | Depdc7 | DEP domain containing 7 |
|
affects expression | ISO | 3 | 90,054,620 | 90,075,902 | RGD:6480464 | CTD | |
| G | Det1 | de-etiolated homolog 1 (Arabidopsis) |
|
affects expression | ISO | 1 | 134,552,235 | 134,566,070 | RGD:6480464 | CTD | |
| G | Dhcr7 | 7-dehydrocholesterol reductase |
|
multiple interactions | ISO | 1 | 204,245,562 | 204,258,913 | RGD:6480464 | CTD | |
| G | Dhdh | dihydrodiol dehydrogenase (dimeric) |
|
affects expression | ISO | 1 | 95,947,679 | 95,957,869 | RGD:6480464 | CTD | |
| G | Dhrs2 | dehydrogenase/reductase (SDR family) member 2 |
|
affects expression | ISO | 15 | 33,286,599 | 33,337,467 | RGD:6480464 | CTD | |
| G | Dhrs3 | dehydrogenase/reductase (SDR family) member 3 |
|
affects expression | ISO | 5 | 163,341,856 | 163,375,604 | RGD:6480464 | CTD | |
| G | Dhx15 | DEAH (Asp-Glu-Ala-His) box polypeptide 15 |
|
affects expression | ISO | 14 | 63,563,251 | 63,601,200 | RGD:6480464 | CTD | |
| G | Dhx9 | DEAH (Asp-Glu-Ala-His) box polypeptide 9 |
|
affects expression | ISO | 13 | 68,471,256 | 68,507,999 | RGD:6480464 | CTD | |
| G | Diablo | diablo, IAP-binding mitochondrial protein |
|
multiple interactions | EXP | 12 | 34,196,347 | 34,209,633 | RGD:6480464 | CTD | |
| G | Diablo | diablo, IAP-binding mitochondrial protein |
|
increases secretion | EXP | 12 | 34,196,347 | 34,209,633 | RGD:6480464 | CTD | |
| G | Diexf | digestive organ expansion factor homolog (zebrafish) |
|
affects expression | ISO | 13 | 108,945,112 | 108,966,381 | RGD:6480464 | CTD | |
| G | Dimt1 | DIM1 dimethyladenosine transferase 1 homolog (S. cerevisiae) |
|
affects expression | ISO | 2 | 38,054,640 | 38,078,326 | RGD:6480464 | CTD | |
| G | Dio2 | deiodinase, iodothyronine, type II |
|
multiple interactions | EXP | 6 | 114,307,758 | 114,317,563 | RGD:6480464 | CTD | |
| G | Dio3 | deiodinase, iodothyronine, type III | multiple interactions | EXP | RGD:6480464 | CTD | |||||
| G | Dio3 | deiodinase, iodothyronine, type III | increases activity | EXP | RGD:6480464 | CTD | |||||
| G | Dio3 | deiodinase, iodothyronine, type III | increases expression | EXP | RGD:6480464 | CTD | |||||
| G | Dkk1 | dickkopf 1 homolog (Xenopus laevis) |
|
increases expression | ISO | 1 | 234,392,743 | 234,396,426 | RGD:6480464 | CTD | |
| G | Dkk1 | dickkopf 1 homolog (Xenopus laevis) |
|
affects expression | ISO | 1 | 234,392,743 | 234,396,426 | RGD:6480464 | CTD | |
| G | Dld | dihydrolipoamide dehydrogenase |
|
multiple interactions | EXP | 6 | 49,185,188 | 49,205,894 | RGD:6480464 | CTD | |
| G | Dlx4 | distal-less homeobox 4 |
|
affects expression | ISO | 10 | 83,822,815 | 83,828,210 | RGD:6480464 | CTD | |
| G | Dnaja1 | DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
affects expression | ISO | 5 | 58,100,794 | 58,111,705 | RGD:6480464 | CTD | |
| G | Dnajb1 | DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
decreases response to substance | ISO | 19 | 26,213,739 | 26,217,480 | RGD:6480464 | CTD | |
| G | Dnajc22 | DnaJ (Hsp40) homolog, subfamily C, member 22 |
|
affects expression | ISO | 7 | 137,875,669 | 137,880,647 | RGD:6480464 | CTD | |
| G | Dnajc7 | DnaJ (Hsp40) homolog, subfamily C, member 7 |
|
affects expression | ISO | 10 | 89,527,163 | 89,563,723 | RGD:6480464 | CTD | |
| G | Dnhd1 | dynein heavy chain domain 1 |
|
affects expression | ISO | 1 | 163,380,065 | 163,467,261 | RGD:6480464 | CTD | |
| G | Dnmt1 | DNA (cytosine-5-)-methyltransferase 1 |
|
increases expression | ISO | 8 | 19,926,995 | 19,973,256 | RGD:6480464 | CTD | |
| G | Dnmt1 | DNA (cytosine-5-)-methyltransferase 1 |
|
decreases response to substance | ISO | 8 | 19,926,995 | 19,973,256 | RGD:6480464 | CTD | |
| G | Dnmt1 | DNA (cytosine-5-)-methyltransferase 1 |
|
decreases response to substance | EXP | 8 | 19,926,995 | 19,973,256 | RGD:6480464 | CTD | |
| G | Dnmt3b | DNA (cytosine-5-)-methyltransferase 3 beta |
|
decreases response to substance | ISO | 3 | 144,030,737 | 144,069,265 | RGD:6480464 | CTD | |
| G | Dnmt3l | DNA (cytosine-5-)-methyltransferase 3-like |
|
affects expression | ISO | 20 | 10,958,957 | 10,973,422 | RGD:6480464 | CTD | |
| G | Dnph1 | 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
|
decreases expression | ISO | 9 | 9,865,096 | 9,867,833 | RGD:6480464 | CTD | |
| G | Dolk | dolichol kinase |
|
affects expression | ISO | 3 | 9,329,640 | 9,331,678 | RGD:6480464 | CTD | |
| G | Dopey1 | dopey family member 1 |
|
affects expression | ISO | 8 | 91,706,333 | 91,808,911 | RGD:6480464 | CTD | |
| G | Dph2 | DPH2 homolog (S. cerevisiae) |
|
affects expression | ISO | 5 | 138,354,594 | 138,357,554 | RGD:6480464 | CTD | |
| G | Dpm1 | dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit |
|
affects expression | ISO | 3 | 159,373,861 | 159,393,404 | RGD:6480464 | CTD | |
| G | Dpp3 | dipeptidylpeptidase 3 |
|
decreases response to substance | ISO | 3 | 138,286,277 | 138,288,887 | RGD:6480464 | CTD | |
| G | Dpys | dihydropyrimidinase |
|
affects expression | ISO | 7 | 75,368,238 | 75,446,160 | RGD:6480464 | CTD | |
| G | Dpysl3 | dihydropyrimidinase-like 3 |
|
affects expression | ISO | 18 | 36,620,669 | 36,680,355 | RGD:6480464 | CTD | |
| G | Dr1 | down-regulator of transcription 1 |
|
affects expression | ISO | 14 | 2,005,938 | 2,017,291 | RGD:6480464 | CTD | |
| G | Dtx3 | deltex homolog 3 (Drosophila) |
|
affects expression | ISO | 7 | 67,145,276 | 67,149,937 | RGD:6480464 | CTD | |
| G | Dusp1 | dual specificity phosphatase 1 |
|
increases expression | ISO | 10 | 16,942,913 | 16,945,696 | RGD:6480464 | CTD | |
| G | Dusp1 | dual specificity phosphatase 1 |
|
affects expression | ISO | 10 | 16,942,913 | 16,945,696 | RGD:6480464 | CTD | |
| G | Dusp1 | dual specificity phosphatase 1 |
|
increases expression | ISO | 10 | 16,942,913 | 16,945,696 | RGD:6480464 | CTD | |
| G | Dusp1 | dual specificity phosphatase 1 |
|
multiple interactions | ISO | 10 | 16,942,913 | 16,945,696 | RGD:6480464 | CTD | |
| G | Dusp14 | dual specificity phosphatase 14 |
|
increases expression | ISO | 10 | 72,336,519 | 72,337,115 | RGD:6480464 | CTD | |
| G | Dusp26 | dual specificity phosphatase 26 (putative) |
|
affects expression | ISO | 16 | 64,952,300 | 64,959,604 | RGD:6480464 | CTD | |
| G | Edc3 | enhancer of mRNA decapping 3 homolog (S. cerevisiae) |
|
affects expression | ISO | 8 | 61,472,266 | 61,517,590 | RGD:6480464 | CTD | |
| G | Egr2 | early growth response 2 |
|
affects expression | ISO | 20 | 21,883,885 | 21,888,177 | RGD:6480464 | CTD | |
| G | Egr4 | early growth response 4 |
|
affects expression | ISO | 4 | 119,765,289 | 119,767,612 | RGD:6480464 | CTD | |
| G | Eif2ak3 | eukaryotic translation initiation factor 2 alpha kinase 3 |
|
affects expression | ISO | 4 | 104,016,940 | 104,078,261 | RGD:6480464 | CTD | |
| G | Eif4a2 | eukaryotic translation initiation factor 4A2 |
|
affects expression | ISO | 11 | 79,950,592 | 79,957,185 | RGD:6480464 | CTD | |
| G | Eif5 | eukaryotic translation initiation factor 5 |
|
affects expression | ISO | 6 | 136,311,381 | 136,318,586 | RGD:6480464 | CTD | |
| G | Elf2 | E74-like factor 2 |
|
affects expression | ISO | 2 | 140,144,023 | 140,221,693 | RGD:6480464 | CTD | |
| G | Elk1 | ELK1, member of ETS oncogene family |
|
decreases expression | ISO | X | 12,597,863 | 12,604,248 | RGD:6480464 | CTD | |
| G | Ell2 | elongation factor RNA polymerase II 2 |
|
affects expression | ISO | 2 | 2,724,984 | 2,794,397 | RGD:6480464 | CTD | |
| G | Eml6 | echinoderm microtubule associated protein like 6 |
|
increases expression | ISO | 14 | 110,774,217 | 110,979,159 | RGD:6480464 | CTD | |
| G | Emp1 | epithelial membrane protein 1 |
|
affects expression | ISO | 4 | 172,315,122 | 172,335,536 | RGD:6480464 | CTD | |
| G | Enc1 | ectodermal-neural cortex 1 |
|
affects expression | ISO | 2 | 27,720,805 | 27,733,168 | RGD:6480464 | CTD | |
| G | Endog | endonuclease G |
|
multiple interactions | EXP | 3 | 9,184,023 | 9,187,524 | RGD:6480464 | CTD | |
| G | Epas1 | endothelial PAS domain protein 1 |
|
multiple interactions | ISO | 6 | 10,203,108 | 10,297,215 | RGD:6480464 | CTD | |
| G | Epas1 | endothelial PAS domain protein 1 |
|
affects expression | ISO | 6 | 10,203,108 | 10,297,215 | RGD:6480464 | CTD | |
| G | Epas1 | endothelial PAS domain protein 1 |
|
increases expression | ISO | 6 | 10,203,108 | 10,297,215 | RGD:6480464 | CTD | |
| G | Epb41l1 | erythrocyte membrane protein band 4.1-like 1 |
|
affects expression | ISO | 3 | 146,876,451 | 146,944,603 | RGD:6480464 | CTD | |
| G | Epc1 | enhancer of polycomb homolog 1 (Drosophila) |
|
affects expression | ISO | 17 | 63,040,151 | 63,131,954 | RGD:6480464 | CTD | |
| G | Epg5 | ectopic P-granules autophagy protein 5 homolog (C. elegans) |
|
multiple interactions | ISO | 18 | 74,846,785 | 74,942,842 | RGD:6480464 | CTD | |
| G | Epha2 | Eph receptor A2 |
|
affects expression | ISO | 5 | 160,185,143 | 160,214,727 | RGD:6480464 | CTD | |
| G | Ephx2 | epoxide hydrolase 2, cytoplasmic |
|
increases expression | ISO | 15 | 45,497,660 | 45,556,101 | RGD:6480464 | CTD | |
| G | Ephx2 | epoxide hydrolase 2, cytoplasmic |
|
affects expression | ISO | 15 | 45,497,660 | 45,556,101 | RGD:6480464 | CTD | |
| G | Epn3 | epsin 3 |
|
affects expression | ISO | 10 | 83,129,023 | 83,137,401 | RGD:6480464 | CTD | |
| G | Epo | erythropoietin |
|
multiple interactions | ISO | 12 | 19,551,768 | 19,555,208 | RGD:6480464 | CTD | |
| G | Epo | erythropoietin |
|
decreases expression | ISO | 12 | 19,551,768 | 19,555,208 | RGD:6480464 | CTD | |
| G | Epo | erythropoietin |
|
decreases expression | EXP | 12 | 19,551,768 | 19,555,208 | RGD:6480464 | CTD | |
| G | Epo | erythropoietin |
|
multiple interactions | EXP | 12 | 19,551,768 | 19,555,208 | RGD:6480464 | CTD | |
| G | Epor | erythropoietin receptor |
|
affects expression | ISO | 8 | 21,061,310 | 21,065,886 | RGD:6480464 | CTD | |
| G | Eppk1 | epiplakin 1 |
|
affects expression | ISO | 7 | 114,135,306 | 114,146,330 | RGD:6480464 | CTD | |
| G | Eprs | glutamyl-prolyl-tRNA synthetase |
|
affects expression | ISO | 13 | 101,375,656 | 101,448,175 | RGD:6480464 | CTD | |
| G | Eps8 | epidermal growth factor receptor pathway substrate 8 |
|
affects expression | ISO | 4 | 174,601,291 | 174,672,247 | RGD:6480464 | CTD | |
| G | Eps8l2 | EPS8-like 2 |
|
affects expression | ISO | 1 | 201,539,214 | 201,560,761 | RGD:6480464 | CTD | |
| G | Epsti1 | epithelial stromal interaction 1 (breast) |
|
affects expression | ISO | 15 | 58,989,876 | 59,088,931 | RGD:6480464 | CTD | |
| G | Erbb2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
affects expression | ISO | 10 | 87,219,157 | 87,242,919 | RGD:6480464 | CTD | |
| G | Erbb2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
decreases expression | ISO | 10 | 87,219,157 | 87,242,919 | RGD:6480464 | CTD | |
| G | Ereg | epiregulin |
|
affects expression | ISO | 14 | 18,521,069 | 18,534,844 | RGD:6480464 | CTD | |
| G | Ethe1 | ethylmalonic encephalopathy 1 |
|
affects expression | ISO | 1 | 79,875,629 | 79,890,681 | RGD:6480464 | CTD | |
| G | Ets2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) |
|
affects expression | ISO | 11 | 36,014,047 | 36,030,833 | RGD:6480464 | CTD | |
| G | Ewsr1 | Ewing sarcoma breakpoint region 1 |
|
affects expression | ISO | 14 | 85,730,483 | 85,758,958 | RGD:6480464 | CTD | |
| G | Exosc3 | exosome component 3 |
|
affects expression | ISO | 5 | 61,880,622 | 61,883,825 | RGD:6480464 | CTD | |
| G | Exosc4 | exosome component 4 |
|
affects expression | ISO | 7 | 114,374,913 | 114,377,655 | RGD:6480464 | CTD | |
| G | Exosc9 | exosome component 9 |
|
affects expression | ISO | 2 | 123,051,592 | 123,062,494 | RGD:6480464 | CTD | |
| G | Ezh2 | enhancer of zeste homolog 2 (Drosophila) |
|
affects expression | ISO | 4 | 75,709,959 | 75,773,279 | RGD:6480464 | CTD | |
| G | Ezr | ezrin |
|
affects expression | ISO | 1 | 41,178,195 | 41,221,735 | RGD:6480464 | CTD | |
| G | F11r | F11 receptor |
|
affects expression | ISO | 13 | 87,369,918 | 87,393,508 | RGD:6480464 | CTD | |
| G | F2r | coagulation factor II (thrombin) receptor |
|
affects expression | ISO | 2 | 25,985,800 | 25,989,072 | RGD:6480464 | CTD | |
| G | F2r | coagulation factor II (thrombin) receptor |
|
increases expression | ISO | 2 | 25,985,800 | 25,989,072 | RGD:6480464 | CTD | |
| G | F7 | coagulation factor VII (serum prothrombin conversion accelerator) |
|
affects expression | ISO | 16 | 81,348,678 | 81,358,991 | RGD:6480464 | CTD | |
| G | Fabp1 | fatty acid binding protein 1, liver |
|
affects expression | ISO | 4 | 104,412,200 | 104,415,981 | RGD:6480464 | CTD | |
| G | Fam105a | family with sequence similarity 105, member A |
|
affects expression | ISO | 2 | 79,545,446 | 79,569,132 | RGD:6480464 | CTD | |
| G | Fam117a | family with sequence similarity 117, member A |
|
affects expression | ISO | 10 | 84,022,262 | 84,067,048 | RGD:6480464 | CTD | |
| G | Fam118b | family with sequence similarity 118, member B |
|
affects expression | ISO | 8 | 34,998,500 | 35,020,233 | RGD:6480464 | CTD | |
| G | Fam151a | family with sequence similarity 151, member A |
|
affects expression | ISO | 5 | 127,809,098 | 127,821,849 | RGD:6480464 | CTD | |
| G | Fam160a2 | family with sequence similarity 160, member A2 |
|
affects expression | ISO | 1 | 163,110,927 | 163,133,590 | RGD:6480464 | CTD | |
| G | Fam173b | family with sequence similarity 173, member B |
|
affects expression | ISO | 2 | 83,693,155 | 83,708,195 | RGD:6480464 | CTD | |
| G | Fam208a | family with sequence similarity 208, member A |
|
increases expression | ISO | 16 | 2,691,237 | 2,747,457 | RGD:6480464 | CTD | |
| G | Fam46a | family with sequence similarity 46, member A |
|
affects expression | ISO | 8 | 90,502,441 | 90,506,129 | RGD:6480464 | CTD | |
| G | Fam46c | family with sequence similarity 46, member C |
|
affects expression | ISO | 2 | 195,462,849 | 195,481,953 | RGD:6480464 | CTD | |
| G | Fam63a | family with sequence similarity 63, member A |
|
affects expression | ISO | 2 | 190,198,815 | 190,206,098 | RGD:6480464 | CTD | |
| G | Fance | Fanconi anemia, complementation group E |
|
affects expression | ISO | 20 | 6,549,701 | 6,566,916 | RGD:6480464 | CTD | |
| G | Farsb | phenylalanyl-tRNA synthetase, beta subunit |
|
affects expression | ISO | 9 | 77,806,573 | 77,865,757 | RGD:6480464 | CTD | |
| G | Fas | Fas (TNF receptor superfamily, member 6) |
|
multiple interactions | ISO | 1 | 238,259,443 | 238,274,745 | RGD:6480464 | CTD | |
| G | Fas | Fas (TNF receptor superfamily, member 6) |
|
decreases expression | EXP | 1 | 238,259,443 | 238,274,745 | RGD:6480464 | CTD | |
| G | Fas | Fas (TNF receptor superfamily, member 6) |
|
increases expression | ISO | 1 | 238,259,443 | 238,274,745 | RGD:6480464 | CTD | |
| G | Faslg | Fas ligand (TNF superfamily, member 6) |
|
increases chemical synthesis | ISO | 13 | 77,472,950 | 77,480,210 | RGD:6480464 | CTD | |
| G | Faslg | Fas ligand (TNF superfamily, member 6) |
|
multiple interactions | ISO | 13 | 77,472,950 | 77,480,210 | RGD:6480464 | CTD | |
| G | Faslg | Fas ligand (TNF superfamily, member 6) |
|
multiple interactions | EXP | 13 | 77,472,950 | 77,480,210 | RGD:6480464 | CTD | |
| G | Faslg | Fas ligand (TNF superfamily, member 6) |
|
multiple interactions | ISO | 13 | 77,472,950 | 77,480,210 | RGD:6480464 | CTD | |
| G | Faslg | Fas ligand (TNF superfamily, member 6) |
|
increases expression | EXP | 13 | 77,472,950 | 77,480,210 | RGD:6480464 | CTD | |
| G | Fastkd1 | FAST kinase domains 1 |
|
affects expression | ISO | 3 | 51,831,438 | 51,857,646 | RGD:6480464 | CTD | |
| G | Fbln1 | fibulin 1 |
|
affects expression | ISO | 7 | 123,208,154 | 123,287,289 | RGD:6480464 | CTD | |
| G | Fbxl15 | F-box and leucine-rich repeat protein 15 |
|
affects expression | ISO | 1 | 251,544,341 | 251,546,582 | RGD:6480464 | CTD | |
| G | Fbxl16 | F-box and leucine-rich repeat protein 16 |
|
affects expression | ISO | 10 | 15,082,199 | 15,085,374 | RGD:6480464 | CTD | |
| G | Fbxl4 | F-box and leucine-rich repeat protein 4 |
|
affects expression | ISO | 5 | 37,156,876 | 37,230,228 | RGD:6480464 | CTD | |
| G | Fbxo3 | F-box protein 3 |
|
affects expression | ISO | 3 | 89,446,724 | 89,479,650 | RGD:6480464 | CTD | |
| G | Fbxo30 | F-box protein 30 |
|
affects expression | ISO | 1 | 5,975,207 | 5,991,214 | RGD:6480464 | CTD | |
| G | Fbxo9 | f-box protein 9 |
|
affects expression | ISO | 8 | 83,056,071 | 83,081,992 | RGD:6480464 | CTD | |
| G | Fdft1 | farnesyl diphosphate farnesyl transferase 1 |
|
multiple interactions | ISO | 15 | 42,425,336 | 42,453,390 | RGD:6480464 | CTD | |
| G | Fdps | farnesyl diphosphate synthase |
|
multiple interactions | ISO | 2 | 181,138,474 | 181,177,903 | RGD:6480464 | CTD | |
| G | Fdx1 | ferredoxin 1 |
|
increases expression | ISO | 8 | 55,291,396 | 55,310,507 | RGD:6480464 | CTD | |
| G | Fdxr | ferredoxin reductase |
|
increases expression | ISO | 10 | 105,342,684 | 105,351,374 | RGD:6480464 | CTD | |
| G | Fech | ferrochelatase |
|
decreases expression | ISO | 18 | 60,675,217 | 60,708,418 | RGD:6480464 | CTD | |
| G | Fen1 | flap structure-specific endonuclease 1 |
|
decreases expression | ISO | 1 | 212,688,118 | 212,692,486 | RGD:6480464 | CTD | |
| G | Fer1l4 | fer-1-like 4 (C. elegans) |
|
affects expression | ISO | 3 | 146,427,611 | 146,463,147 | RGD:6480464 | CTD | |
| G | Fgd3 | FYVE, RhoGEF and PH domain containing 3 |
|
affects expression | ISO | 17 | 21,292,539 | 21,343,264 | RGD:6480464 | CTD | |
| G | Fgf1 | fibroblast growth factor 1 (acidic) |
|
decreases response to substance | ISO | 18 | 31,785,480 | 31,806,452 | RGD:6480464 | CTD | |
| G | Fgf2 | fibroblast growth factor 2 |
|
multiple interactions | ISO | 2 | 123,893,314 | 123,947,136 | RGD:6480464 | CTD | |
| G | Fgf7 | fibroblast growth factor 7 |
|
decreases response to substance | ISO | 3 | 113,468,427 | 113,517,538 | RGD:6480464 | CTD | |
| G | Fgfbp1 | fibroblast growth factor binding protein 1 |
|
affects expression | ISO | 14 | 72,242,271 | 72,243,353 | RGD:6480464 | CTD | |
| G | Fgfr1 | Fibroblast growth factor receptor 1 |
|
multiple interactions | ISO | 16 | 70,869,974 | 70,910,045 | RGD:6480464 | CTD | |
| G | Fgfr1 | Fibroblast growth factor receptor 1 |
|
decreases expression | ISO | 16 | 70,869,974 | 70,910,045 | RGD:6480464 | CTD | |
| G | Fgfr1op | Fgfr1 oncogene partner |
|
affects expression | ISO | 1 | 47,176,365 | 47,205,468 | RGD:6480464 | CTD | |
| G | Fgfr2 | fibroblast growth factor receptor 2 |
|
affects expression | ISO | 1 | 189,482,975 | 189,589,279 | RGD:6480464 | CTD | |
| G | Fgfr2 | fibroblast growth factor receptor 2 |
|
decreases expression | ISO | 1 | 189,482,975 | 189,589,279 | RGD:6480464 | CTD | |
| G | Fgfr2 | fibroblast growth factor receptor 2 |
|
multiple interactions | ISO | 1 | 189,482,975 | 189,589,279 | RGD:6480464 | CTD | |
| G | Fgg | fibrinogen gamma chain |
|
affects expression | ISO | 2 | 174,727,312 | 174,734,594 | RGD:6480464 | CTD | |
| G | Fgg | fibrinogen gamma chain |
|
increases expression | ISO | 2 | 174,727,312 | 174,734,594 | RGD:6480464 | CTD | |
| G | Fh | fumarate hydratase |
|
affects expression | ISO | 13 | 91,329,837 | 91,355,722 | RGD:6480464 | CTD | |
| G | Fhl2 | four and a half LIM domains 2 |
|
affects expression | ISO | 9 | 42,319,997 | 42,349,055 | RGD:6480464 | CTD | |
| G | Fignl1 | fidgetin-like 1 |
|
affects expression | ISO | 14 | 92,685,445 | 92,693,967 | RGD:6480464 | CTD | |
| G | Fjx1 | four jointed box 1 (Drosophila) |
|
affects expression | ISO | 3 | 87,640,138 | 87,642,239 | RGD:6480464 | CTD | |
| G | Fkbp1a | FK506 binding protein 1a |
|
increases expression | EXP | 3 | 141,861,237 | 141,880,797 | RGD:6480464 | CTD | |
| G | Flcn | folliculin |
|
affects expression | ISO | 10 | 46,110,527 | 46,129,613 | RGD:6480464 | CTD | |
| G | Flrt3 | fibronectin leucine rich transmembrane protein 3 |
|
affects expression | ISO | 3 | 128,922,726 | 128,934,866 | RGD:6480464 | CTD | |
| G | Fmo1 | flavin containing monooxygenase 1 |
|
decreases expression | ISO | 13 | 78,503,770 | 78,536,359 | RGD:6480464 | CTD | |
| G | Fmod | fibromodulin |
|
affects expression | ISO | 13 | 46,987,714 | 46,998,331 | RGD:6480464 | CTD | |
| G | Fn1 | fibronectin 1 |
|
multiple interactions | ISO | 9 | 70,702,181 | 70,771,155 | RGD:6480464 | CTD | |
| G | Fn1 | fibronectin 1 |
|
increases expression | ISO | 9 | 70,702,181 | 70,771,155 | RGD:6480464 | CTD | |
| G | Fn1 | fibronectin 1 |
|
increases secretion | ISO | 9 | 70,702,181 | 70,771,155 | RGD:6480464 | CTD | |
| G | Foxc1 | forkhead box C1 |
|
affects expression | ISO | 17 | 39,026,186 | 39,030,163 | RGD:6480464 | CTD | |
| G | Ftl | ferritin, light polypeptide |
|
increases expression | ISO | 1 | 95,929,248 | 95,931,092 | RGD:6480464 | CTD | |
| G | Ftl | ferritin, light polypeptide |
|
increases degradation | ISO | 1 | 95,929,248 | 95,931,092 | RGD:6480464 | CTD | |
| G | Ftl | ferritin, light polypeptide |
|
multiple interactions | ISO | 1 | 95,929,248 | 95,931,092 | RGD:6480464 | CTD | |
| G | Ftmt | ferritin mitochondrial |
|
increases expression | ISO | 18 | 47,678,332 | 47,679,581 | RGD:6480464 | CTD | |
| G | Fut1 | fucosyltransferase 1 |
|
affects expression | ISO | 1 | 96,085,914 | 96,089,332 | RGD:6480464 | CTD | |
| G | Fxyd5 | FXYD domain-containing ion transport regulator 5 |
|
increases expression | ISO | 1 | 86,076,279 | 86,085,681 | RGD:6480464 | CTD | |
| G | Fyttd1 | forty-two-three domain containing 1 |
|
affects expression | ISO | 11 | 69,700,526 | 69,720,622 | RGD:6480464 | CTD | |
| G | Fzd2 | frizzled family receptor 2 |
|
affects expression | ISO | 10 | 91,709,222 | 91,711,132 | RGD:6480464 | CTD | |
| G | Fzd4 | frizzled family receptor 4 |
|
affects expression | ISO | 1 | 145,953,743 | 145,957,666 | RGD:6480464 | CTD | |
| G | Fzd5 | frizzled family receptor 5 |
|
affects expression | ISO | 9 | 63,386,990 | 63,388,747 | RGD:6480464 | CTD | |
| G | Fzd6 | frizzled family receptor 6 |
|
affects expression | ISO | 7 | 74,562,307 | 74,594,014 | RGD:6480464 | CTD | |
| G | G0s2 | G0/G1switch 2 |
|
affects expression | ISO | 13 | 109,121,297 | 109,122,209 | RGD:6480464 | CTD | |
| G | G3bp2 | GTPase activating protein (SH3 domain) binding protein 2 |
|
affects expression | ISO | 14 | 17,556,967 | 17,588,259 | RGD:6480464 | CTD | |
| G | G6pd | glucose-6-phosphate dehydrogenase |
|
increases activity | ISO | X | 160,186,450 | 160,192,316 | RGD:6480464 | CTD | |
| G | G6pd | glucose-6-phosphate dehydrogenase |
|
increases activity | ISO | X | 160,186,450 | 160,192,316 | RGD:6480464 | CTD | |
| G | Gaa | glucosidase, alpha, acid | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Gab2 | GRB2-associated binding protein 2 |
|
affects expression | ISO | 1 | 154,348,777 | 154,544,906 | RGD:6480464 | CTD | |
| G | Gabarapl1 | GABA(A) receptor-associated protein like 1 |
|
affects expression | ISO | 4 | 166,802,106 | 166,811,249 | RGD:6480464 | CTD | |
| G | Gabpb2 | GA binding protein transcription factor, beta subunit 2 |
|
affects expression | ISO | 2 | 190,094,254 | 190,114,114 | RGD:6480464 | CTD | |
| G | Gad1 | glutamate decarboxylase 1 |
|
decreases response to substance | ISO | 3 | 52,789,370 | 52,830,038 | RGD:6480464 | CTD | |
| G | Gad1 | glutamate decarboxylase 1 |
|
affects expression | ISO | 3 | 52,789,370 | 52,830,038 | RGD:6480464 | CTD | |
| G | Gadd45a | growth arrest and DNA-damage-inducible, alpha |
|
multiple interactions | ISO | 4 | 96,649,941 | 96,652,243 | RGD:6480464 | CTD | |
| G | Gal | galanin/GMAP prepropeptide |
|
affects expression | ISO | 1 | 205,936,352 | 205,941,215 | RGD:6480464 | CTD | |
| G | Gal3st1 | galactose-3-O-sulfotransferase 1 |
|
affects expression | ISO | 14 | 84,636,490 | 84,642,269 | RGD:6480464 | CTD | |
| G | Galm | galactose mutarotase (aldose 1-epimerase) |
|
affects expression | ISO | 6 | 3,024,123 | 3,078,720 | RGD:6480464 | CTD | |
| G | Gapdh | glyceraldehyde-3-phosphate dehydrogenase |
|
increases expression | ISO | 4 | 161,282,215 | 161,286,090 | RGD:6480464 | CTD | |
| G | Gapdh | glyceraldehyde-3-phosphate dehydrogenase |
|
decreases expression | ISO | 4 | 161,282,215 | 161,286,090 | RGD:6480464 | CTD | |
| G | Gapdh | glyceraldehyde-3-phosphate dehydrogenase |
|
affects expression | ISO | 4 | 161,282,215 | 161,286,090 | RGD:6480464 | CTD | |
| G | Garnl3 | GTPase activating Rap/RanGAP domain-like 3 |
|
affects expression | ISO | 3 | 11,976,369 | 12,076,318 | RGD:6480464 | CTD | |
| G | Gart | phosphoribosylglycinamide formyltransferase |
|
affects expression | ISO | 11 | 31,594,859 | 31,620,110 | RGD:6480464 | CTD | |
| G | Gas2l1 | growth arrest-specific 2 like 1 |
|
affects expression | ISO | 14 | 85,716,617 | 85,726,368 | RGD:6480464 | CTD | |
| G | Gas6 | growth arrest specific 6 |
|
multiple interactions | EXP | 16 | 80,900,159 | 80,930,929 | RGD:6480464 | CTD | |
| G | Gata3 | GATA binding protein 3 |
|
affects expression | ISO | 17 | 79,991,587 | 80,011,574 | RGD:6480464 | CTD | |
| G | Gatm | glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
|
affects expression | ISO | 3 | 109,558,043 | 109,565,432 | RGD:6480464 | CTD | |
| G | Gchfr | GTP cyclohydrolase I feedback regulator |
|
affects expression | ISO | 3 | 105,683,288 | 105,687,349 | RGD:6480464 | CTD | |
| G | Gclc | glutamate-cysteine ligase, catalytic subunit |
|
increases expression | ISO | 8 | 82,724,429 | 82,762,848 | RGD:6480464 | CTD | |
| G | Gclc | glutamate-cysteine ligase, catalytic subunit |
|
affects expression | ISO | 8 | 82,724,429 | 82,762,848 | RGD:6480464 | CTD | |
| G | Gclm | glutamate cysteine ligase, modifier subunit |
|
increases expression | ISO | 2 | 218,895,434 | 218,915,491 | RGD:6480464 | CTD | |
| G | Gcnt1 | glucosaminyl (N-acetyl) transferase 1, core 2 |
|
affects expression | ISO | 1 | 220,824,976 | 220,829,980 | RGD:6480464 | CTD | |
| G | Gcnt3 | glucosaminyl (N-acetyl) transferase 3, mucin type |
|
affects expression | ISO | 8 | 74,470,610 | 74,474,086 | RGD:6480464 | CTD | |
| G | Gdf15 | growth differentiation factor 15 |
|
affects expression | ISO | 16 | 19,310,882 | 19,313,465 | RGD:6480464 | CTD | |
| G | Gdf15 | growth differentiation factor 15 |
|
increases expression | ISO | 16 | 19,310,882 | 19,313,465 | RGD:6480464 | CTD | |
| G | Gdf15 | growth differentiation factor 15 |
|
increases expression | ISO | 16 | 19,310,882 | 19,313,465 | RGD:6480464 | CTD | |
| G | Gdnf | glial cell derived neurotrophic factor |
|
decreases expression | ISO | 2 | 57,399,312 | 57,424,030 | RGD:6480464 | CTD | |
| G | Gdnf | glial cell derived neurotrophic factor |
|
multiple interactions | ISO | 2 | 57,399,312 | 57,424,030 | RGD:6480464 | CTD | |
| G | Gdpd5 | glycerophosphodiester phosphodiesterase domain containing 5 |
|
affects expression | ISO | 1 | 156,703,241 | 156,794,530 | RGD:6480464 | CTD | |
| G | Gemin5 | gem (nuclear organelle) associated protein 5 |
|
affects expression | ISO | 10 | 43,754,719 | 43,796,361 | RGD:6480464 | CTD | |
| G | Gfap | glial fibrillary acidic protein |
|
multiple interactions | ISO | 10 | 92,059,881 | 92,068,555 | RGD:6480464 | CTD | |
| G | Gfap | glial fibrillary acidic protein |
|
increases expression | ISO | 10 | 92,059,881 | 92,068,555 | RGD:6480464 | CTD | |
| G | Gfer | growth factor, augmenter of liver regeneration |
|
affects response to substance | ISO | 10 | 13,946,311 | 13,948,665 | RGD:6480464 | CTD | |
| G | Ghr | growth hormone receptor |
|
decreases response to substance | ISO | 2 | 52,496,517 | 52,658,066 | RGD:6480464 | CTD | |
| G | Gins3 | GINS complex subunit 3 (Psf3 homolog) |
|
affects expression | ISO | 19 | 9,876,690 | 9,885,226 | RGD:6480464 | CTD | |
| G | Gja1 | gap junction protein, alpha 1 |
|
increases phosphorylation | EXP | 20 | 35,409,815 | 35,422,262 | RGD:6480464 | CTD | |
| G | Gja1 | gap junction protein, alpha 1 |
|
multiple interactions | EXP | 20 | 35,409,815 | 35,422,262 | RGD:6480464 | CTD | |
| G | Gja1 | gap junction protein, alpha 1 |
|
decreases expression | ISO | 20 | 35,409,815 | 35,422,262 | RGD:6480464 | CTD | |
| G | Glb1 | galactosidase, beta 1 |
|
affects expression | ISO | 8 | 118,791,550 | 118,864,281 | RGD:6480464 | CTD | |
| G | Glrx | glutaredoxin (thioltransferase) |
|
increases expression | ISO | 2 | 2,888,605 | 2,899,216 | RGD:6480464 | CTD | |
| G | Gls | glutaminase |
|
affects expression | ISO | 9 | 46,380,165 | 46,452,974 | RGD:6480464 | CTD | |
| G | Glt8d1 | glycosyltransferase 8 domain containing 1 |
|
affects expression | ISO | 16 | 6,429,357 | 6,444,262 | RGD:6480464 | CTD | |
| G | Glyctk | glycerate kinase | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Gnas | GNAS complex locus |
|
decreases expression | ISO | 3 | 165,213,399 | 165,214,551 | RGD:6480464 | CTD | |
| G | Gnaz | guanine nucleotide binding protein (G protein), alpha z polypeptide |
|
affects expression | ISO | 20 | 14,148,003 | 14,174,136 | RGD:6480464 | CTD | |
| G | Gnb1 | guanine nucleotide binding protein (G protein), beta polypeptide 1 |
|
decreases expression | ISO | 5 | 172,341,135 | 172,386,772 | RGD:6480464 | CTD | |
| G | Gnb2 | guanine nucleotide binding protein (G protein), beta polypeptide 2 |
|
decreases expression | ISO | 12 | 19,597,312 | 19,602,329 | RGD:6480464 | CTD | |
| G | Gne | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
|
affects expression | ISO | 5 | 60,506,171 | 60,536,403 | RGD:6480464 | CTD | |
| G | Gnl2 | guanine nucleotide binding protein-like 2 (nucleolar) |
|
affects expression | ISO | 5 | 144,373,848 | 144,399,235 | RGD:6480464 | CTD | |
| G | Gnl3 | guanine nucleotide binding protein-like 3 (nucleolar) |
|
affects expression | ISO | 16 | 6,444,437 | 6,450,375 | RGD:6480464 | CTD | |
| G | Gnrh1 | gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
affects expression | ISO | 15 | 47,303,309 | 47,307,517 | RGD:6480464 | CTD | |
| G | Gpank1 | G patch domain and ankyrin repeats 1 |
|
affects expression | ISO | 20 | 3,761,295 | 3,764,338 | RGD:6480464 | CTD | |
| G | Gpatc2 | G patch domain containing 2 |
|
affects expression | ISO | 13 | 103,353,994 | 103,371,422 | RGD:6480464 | CTD | |
| G | Gpatch4 | G patch domain containing 4 |
|
affects expression | ISO | 2 | 180,123,437 | 180,132,225 | RGD:6480464 | CTD | |
| G | Gpatch8 | G patch domain containing 8 |
|
multiple interactions | ISO | 10 | 91,580,259 | 91,660,338 | RGD:6480464 | CTD | |
| G | Gpkow | G patch domain and KOW motifs |
|
affects expression | ISO | X | 26,832,382 | 26,846,629 | RGD:6480464 | CTD | |
| G | Gpn3 | GPN-loop GTPase 3 |
|
affects expression | ISO | 12 | 35,384,028 | 35,392,646 | RGD:6480464 | CTD | |
| G | Gprc5a | G protein-coupled receptor, family C, group 5, member A |
|
affects expression | ISO | 4 | 171,987,364 | 172,006,276 | RGD:6480464 | CTD | |
| G | Gprin3 | GPRIN family member 3 |
|
increases expression | ISO | 4 | 88,376,454 | 88,378,742 | RGD:6480464 | CTD | |
| G | Gpt2 | glutamic pyruvate transaminase (alanine aminotransferase) 2 |
|
affects expression | ISO | 19 | 22,884,586 | 22,915,553 | RGD:6480464 | CTD | |
| G | Gpx1 | glutathione peroxidase 1 | affects abundance | ISO | RGD:6480464 | CTD | |||||
| G | Gpx1 | glutathione peroxidase 1 | decreases response to substance | ISO | RGD:6480464 | CTD | |||||
| G | Gpx1 | glutathione peroxidase 1 | increases reduction | ISO | RGD:6480464 | CTD | |||||
| G | Gpx1 | glutathione peroxidase 1 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Gpx1 | glutathione peroxidase 1 | decreases response to substance | ISO | RGD:6480464 | CTD | |||||
| G | Gpx1 | glutathione peroxidase 1 | multiple interactions | EXP | RGD:6480464 | CTD | |||||
| G | Gpx1 | glutathione peroxidase 1 | increases metabolic processing | ISO | RGD:6480464 | CTD | |||||
| G | Gpx2 | glutathione peroxidase 2 |
|
increases reduction | ISO | 6 | 99,372,418 | 99,376,230 | RGD:6480464 | CTD | |
| G | Gpx2 | glutathione peroxidase 2 |
|
affects expression | ISO | 6 | 99,372,418 | 99,376,230 | RGD:6480464 | CTD | |
| G | Gpx2 | glutathione peroxidase 2 |
|
increases expression | ISO | 6 | 99,372,418 | 99,376,230 | RGD:6480464 | CTD | |
| G | Gpx3 | glutathione peroxidase 3 |
|
multiple interactions | ISO | 10 | 40,311,094 | 40,319,382 | RGD:6480464 | CTD | |
| G | Gpx4 | glutathione peroxidase 4 |
|
decreases response to substance | ISO | 7 | 11,162,521 | 11,165,318 | RGD:6480464 | CTD | |
| G | Gpx4 | glutathione peroxidase 4 |
|
increases response to substance | ISO | 7 | 11,162,521 | 11,165,318 | RGD:6480464 | CTD | |
| G | Gpx4 | glutathione peroxidase 4 |
|
decreases response to substance | ISO | 7 | 11,162,521 | 11,165,318 | RGD:6480464 | CTD | |
| G | Gpx4 | glutathione peroxidase 4 |
|
decreases response to substance | ISO | 7 | 11,162,521 | 11,165,318 | RGD:6480464 | CTD | |
| G | Gpx5 | glutathione peroxidase 5 | affects metabolic processing | ISO | RGD:6480464 | CTD | |||||
| G | Grin2c | glutamate receptor, ionotropic, N-methyl D-aspartate 2C |
|
affects expression | ISO | 10 | 105,323,371 | 105,340,976 | RGD:6480464 | CTD | |
| G | Grin2c | glutamate receptor, ionotropic, N-methyl D-aspartate 2C |
|
increases expression | ISO | 10 | 105,323,371 | 105,340,976 | RGD:6480464 | CTD | |
| G | Grk5 | G protein-coupled receptor kinase 5 |
|
affects expression | ISO | 1 | 267,495,534 | 267,693,144 | RGD:6480464 | CTD | |
| G | Grpel2 | GrpE-like 2, mitochondrial |
|
affects expression | ISO | 18 | 57,691,610 | 57,703,850 | RGD:6480464 | CTD | |
| G | Gsn | gelsolin |
|
affects expression | ISO | 3 | 14,360,245 | 14,386,313 | RGD:6480464 | CTD | |
| G | Gsr | glutathione reductase |
|
multiple interactions | EXP | 16 | 62,255,562 | 62,298,458 | RGD:6480464 | CTD | |
| G | Gsr | glutathione reductase |
|
increases activity | ISO | 16 | 62,255,562 | 62,298,458 | RGD:6480464 | CTD | |
| G | Gsr | glutathione reductase |
|
decreases expression | ISO | 16 | 62,255,562 | 62,298,458 | RGD:6480464 | CTD | |
| G | Gsr | glutathione reductase |
|
decreases activity | EXP | 16 | 62,255,562 | 62,298,458 | RGD:6480464 | CTD | |
| G | Gsta1 | glutathione S-transferase alpha 1 |
|
affects expression | ISO | 9 | 20,051,501 | 20,068,146 | RGD:6480464 | CTD | |
| G | Gsta1 | glutathione S-transferase alpha 1 |
|
increases expression | EXP | 9 | 20,051,501 | 20,068,146 | RGD:6480464 | CTD | |
| G | Gsta2 | glutathione S-transferase alpha 2 |
|
increases expression | ISO | 8 | 83,299,249 | 83,312,958 | RGD:6480464 | CTD | |
| G | Gsta4 | glutathione S-transferase alpha 4 |
|
multiple interactions | ISO | 8 | 83,165,139 | 83,183,055 | RGD:6480464 | CTD | |
| G | Gsta4 | glutathione S-transferase alpha 4 |
|
decreases response to substance | ISO | 8 | 83,165,139 | 83,183,055 | RGD:6480464 | CTD | |
| G | Gsta4 | glutathione S-transferase alpha 4 |
|
increases expression | ISO | 8 | 83,165,139 | 83,183,055 | RGD:6480464 | CTD | |
| G | Gsta5 | glutathione S-transferase alpha 5 |
|
affects expression | ISO | 8 | 83,202,554 | 83,211,997 | RGD:6480464 | CTD | |
| G | Gsta5 | glutathione S-transferase alpha 5 |
|
decreases response to substance | EXP | 8 | 83,202,554 | 83,211,997 | RGD:6480464 | CTD | |
| G | Gstm2 | glutathione S-transferase mu 2 |
|
increases expression | ISO | 2 | 203,549,022 | 203,553,380 | RGD:6480464 | CTD | |
| G | Gstp1 | glutathione S-transferase pi 1 |
|
decreases response to substance | ISO | 1 | 206,627,398 | 206,629,866 | RGD:6480464 | CTD | |
| G | Gstp1 | glutathione S-transferase pi 1 |
|
affects localization | ISO | 1 | 206,627,398 | 206,629,866 | RGD:6480464 | CTD | |
| G | Gstp1 | glutathione S-transferase pi 1 |
|
multiple interactions | ISO | 1 | 206,627,398 | 206,629,866 | RGD:6480464 | CTD | |
| G | Hccs | holocytochrome c synthase |
|
affects expression | ISO | X | 45,617,395 | 45,626,790 | RGD:6480464 | CTD | |
| G | Hdac1 | histone deacetylase 1 |
|
decreases expression | ISO | 5 | 148,672,515 | 148,699,810 | RGD:6480464 | CTD | |
| G | Hdac2 | histone deacetylase 2 |
|
multiple interactions | ISO | 20 | 41,162,093 | 41,186,492 | RGD:6480464 | CTD | |
| G | Hdac2 | histone deacetylase 2 |
|
decreases activity | ISO | 20 | 41,162,093 | 41,186,492 | RGD:6480464 | CTD | |
| G | Hdac6 | histone deacetylase 6 |
|
affects expression | ISO | X | 26,585,852 | 26,606,999 | RGD:6480464 | CTD | |
| G | Heatr1 | HEAT repeat containing 1 |
|
affects expression | ISO | 17 | 68,613,162 | 68,654,896 | RGD:6480464 | CTD | |
| G | Heph | hephaestin |
|
affects expression | ISO | X | 84,033,540 | 84,138,728 | RGD:6480464 | CTD | |
| G | Hes1 | hairy and enhancer of split 1 (Drosophila) |
|
affects expression | ISO | 11 | 72,603,482 | 72,605,673 | RGD:6480464 | CTD | |
| G | Heyl | hairy/enhancer-of-split related with YRPW motif-like |
|
affects expression | ISO | 5 | 142,544,185 | 142,561,176 | RGD:6480464 | CTD | |
| G | Hgf | hepatocyte growth factor |
|
decreases expression | ISO | 4 | 14,864,357 | 14,932,513 | RGD:6480464 | CTD | |
| G | Hgfac | HGF activator |
|
decreases expression | ISO | 14 | 81,348,282 | 81,354,836 | RGD:6480464 | CTD | |
| G | Hhat | hedgehog acyltransferase |
|
affects expression | ISO | 13 | 108,411,459 | 108,651,307 | RGD:6480464 | CTD | |
| G | Hif1a | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions | ISO | 6 | 96,419,024 | 96,463,891 | RGD:6480464 | CTD | |
| G | Hif1a | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
increases expression | ISO | 6 | 96,419,024 | 96,463,891 | RGD:6480464 | CTD | |
| G | Hif1a | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
increases expression | ISO | 6 | 96,419,024 | 96,463,891 | RGD:6480464 | CTD | |
| G | Hif3a | hypoxia inducible factor 3, alpha subunit |
|
multiple interactions | ISO | 1 | 77,377,465 | 77,408,704 | RGD:6480464 | CTD | |
| G | Hif3a | hypoxia inducible factor 3, alpha subunit |
|
increases expression | ISO | 1 | 77,377,465 | 77,408,704 | RGD:6480464 | CTD | |
| G | Hint1 | histidine triad nucleotide binding protein 1 |
|
decreases expression | ISO | 10 | 40,271,895 | 40,275,640 | RGD:6480464 | CTD | |
| G | Hint3 | histidine triad nucleotide binding protein 3 |
|
affects expression | ISO | 1 | 27,719,396 | 27,729,255 | RGD:6480464 | CTD | |
| G | Hist1h2bb | histone cluster 1, H2bb |
|
affects expression | ISO | 17 | 48,512,993 | 48,513,373 | RGD:6480464 | CTD | |
| G | Hist2h2aa3 | histone cluster 2, H2aa3 |
|
affects expression | ISO | 2 | 191,052,007 | 191,052,604 | RGD:6480464 | CTD | |
| G | Hist3h2bb | histone cluster 3, H2bb |
|
affects expression | ISO | 10 | 45,244,935 | 45,245,682 | RGD:6480464 | CTD | |
| G | Hist3h3 | histone cluster 3, H3 |
|
multiple interactions | ISO | 10 | 45,252,993 | 45,253,403 | RGD:6480464 | CTD | |
| G | Hist3h3 | histone cluster 3, H3 |
|
decreases acetylation | ISO | 10 | 45,252,993 | 45,253,403 | RGD:6480464 | CTD | |
| G | Hk2 | hexokinase 2 |
|
affects expression | ISO | 4 | 116,925,725 | 116,975,211 | RGD:6480464 | CTD | |
| G | Hlcs | holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase) |
|
affects expression | ISO | 11 | 34,382,010 | 34,539,032 | RGD:6480464 | CTD | |
| G | Hmga1 | high mobility group AT-hook 1 |
|
decreases expression | ISO | 20 | 5,769,052 | 5,772,269 | RGD:6480464 | CTD | |
| G | Hmgb1 | high mobility group box 1 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Hmgb1 | high mobility group box 1 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Hmgb1 | high mobility group box 1 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Hmgb1 | high mobility group box 1 | affects localization | ISO | RGD:6480464 | CTD | |||||
| G | Hmgb1 | high mobility group box 1 | increases secretion | ISO | RGD:6480464 | CTD | |||||
| G | Hmgcr | 3-hydroxy-3-methylglutaryl-CoA reductase |
|
increases expression | ISO | 2 | 27,127,504 | 27,149,580 | RGD:6480464 | CTD | |
| G | Hmgcr | 3-hydroxy-3-methylglutaryl-CoA reductase |
|
multiple interactions | ISO | 2 | 27,127,504 | 27,149,580 | RGD:6480464 | CTD | |
| G | Hmgcs1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
multiple interactions | ISO | 2 | 51,737,090 | 51,754,583 | RGD:6480464 | CTD | |
| G | Hmgcs1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
affects expression | ISO | 2 | 51,737,090 | 51,754,583 | RGD:6480464 | CTD | |
| G | Hmgcs1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
increases expression | EXP | 2 | 51,737,090 | 51,754,583 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
multiple interactions | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
multiple interactions | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
multiple interactions | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
increases expression | EXP | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
multiple interactions | EXP | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox2 | heme oxygenase (decycling) 2 |
|
decreases response to substance | ISO | 10 | 10,914,157 | 10,929,448 | RGD:6480464 | CTD | |
| G | Hnf4a | hepatocyte nuclear factor 4, alpha |
|
multiple interactions | ISO | 3 | 154,459,863 | 154,482,825 | RGD:6480464 | CTD | |
| G | Hnrnpab | heterogeneous nuclear ribonucleoprotein A/B |
|
affects expression | ISO | 10 | 37,117,285 | 37,123,177 | RGD:6480464 | CTD | |
| G | Hnrnpc | heterogeneous nuclear ribonucleoprotein C (C1/C2) |
|
multiple interactions | ISO | 15 | 27,516,839 | 27,546,646 | RGD:6480464 | CTD | |
| G | Hnrpd | heterogeneous nuclear ribonucleoprotein D |
|
affects expression | ISO | 14 | 10,917,674 | 10,935,989 | RGD:6480464 | CTD | |
| G | Homer1 | homer homolog 1 (Drosophila) | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Hoxa1 | homeo box A1 |
|
affects expression | ISO | 4 | 80,456,728 | 80,458,388 | RGD:6480464 | CTD | |
| G | Hoxa4 | homeo box A4 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Hoxa7 | homeobox A7 |
|
affects expression | ISO | 4 | 80,515,622 | 80,517,521 | RGD:6480464 | CTD | |
| G | Hoxb6 | homeo box B6 |
|
affects expression | ISO | 10 | 85,030,558 | 85,033,604 | RGD:6480464 | CTD | |
| G | Hoxb9 | homeo box B9 |
|
affects expression | ISO | 10 | 85,002,254 | 85,005,760 | RGD:6480464 | CTD | |
| G | Hras | Harvey rat sarcoma virus oncogene |
|
increases expression | ISO | 1 | 201,385,705 | 201,388,987 | RGD:6480464 | CTD | |
| G | Hsd17b11 | hydroxysteroid (17-beta) dehydrogenase 11 |
|
affects expression | ISO | 14 | 6,859,573 | 6,891,511 | RGD:6480464 | CTD | |
| G | Hsd17b2 | hydroxysteroid (17-beta) dehydrogenase 2 |
|
affects expression | ISO | 19 | 47,729,519 | 47,802,933 | RGD:6480464 | CTD | |
| G | Hspa14 | heat shock protein 14 |
|
affects expression | ISO | 17 | 85,848,593 | 85,869,375 | RGD:6480464 | CTD | |
| G | Hspa1a | heat shock protein 1A |
|
multiple interactions | ISO | 20 | 3,945,716 | 3,959,552 | RGD:6480464 | CTD | |
| G | Hspa1a | heat shock protein 1A |
|
affects localization | ISO | 20 | 3,945,716 | 3,959,552 | RGD:6480464 | CTD | |
| G | Hspa1a | heat shock protein 1A |
|
affects expression | ISO | 20 | 3,945,716 | 3,959,552 | RGD:6480464 | CTD | |
| G | Hspa1a | heat shock protein 1A |
|
multiple interactions | ISO | 20 | 3,945,716 | 3,959,552 | RGD:6480464 | CTD | |
| G | Hspa1a | heat shock protein 1A |
|
increases expression | ISO | 20 | 3,945,716 | 3,959,552 | RGD:6480464 | CTD | |
| G | Hspa1a | heat shock protein 1A |
|
multiple interactions | ISO | 20 | 3,945,716 | 3,959,552 | RGD:6480464 | CTD | |
| G | Hspa1a | heat shock protein 1A |
|
affects localization | ISO | 20 | 3,945,716 | 3,959,552 | RGD:6480464 | CTD | |
| G | Hspa1b | heat shock protein 1B |
|
increases expression | ISO | 20 | 3,955,274 | 3,957,748 | RGD:6480464 | CTD | |
| G | Hspa2 | heat shock protein 2 |
|
affects expression | ISO | 6 | 99,000,541 | 99,003,041 | RGD:6480464 | CTD | |
| G | Hspb1 | heat shock protein 1 |
|
increases expression | ISO | 12 | 21,911,223 | 21,912,784 | RGD:6480464 | CTD | |
| G | Hspb1 | heat shock protein 1 |
|
increases phosphorylation | ISO | 12 | 21,911,223 | 21,912,784 | RGD:6480464 | CTD | |
| G | Hspb8 | heat shock protein B8 |
|
increases expression | ISO | 12 | 41,407,166 | 41,421,565 | RGD:6480464 | CTD | |
| G | Hspe1 | heat shock protein 1 (chaperonin 10) |
|
affects expression | ISO | 9 | 53,895,333 | 53,898,421 | RGD:6480464 | CTD | |
| G | Htatip2 | HIV-1 Tat interactive protein 2 |
|
affects expression | ISO | 1 | 99,563,187 | 99,577,802 | RGD:6480464 | CTD | |
| G | Htatsf1 | HIV-1 Tat specific factor 1 |
|
affects expression | ISO | X | 141,697,471 | 141,711,652 | RGD:6480464 | CTD | |
| G | Hyal3 | hyaluronoglucosaminidase 3 |
|
affects expression | ISO | 8 | 112,828,150 | 112,833,785 | RGD:6480464 | CTD | |
| G | Hypk | Huntingtin interacting protein K |
|
affects expression | ISO | 3 | 108,262,767 | 108,264,495 | RGD:6480464 | CTD | |
| G | Icam1 | intercellular adhesion molecule 1 |
|
multiple interactions | ISO | 8 | 20,040,177 | 20,051,939 | RGD:6480464 | CTD | |
| G | Icam1 | intercellular adhesion molecule 1 |
|
affects expression | ISO | 8 | 20,040,177 | 20,051,939 | RGD:6480464 | CTD | |
| G | Id1 | inhibitor of DNA binding 1 |
|
affects expression | ISO | 3 | 143,086,162 | 143,087,289 | RGD:6480464 | CTD | |
| G | Id1 | inhibitor of DNA binding 1 |
|
decreases expression | ISO | 3 | 143,086,162 | 143,087,289 | RGD:6480464 | CTD | |
| G | Id2 | inhibitor of DNA binding 2 |
|
affects expression | ISO | 6 | 42,781,476 | 42,783,307 | RGD:6480464 | CTD | |
| G | Id3 | inhibitor of DNA binding 3 |
|
affects expression | ISO | 5 | 154,934,138 | 154,935,707 | RGD:6480464 | CTD | |
| G | Idua | iduronidase, alpha-L- | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Ier2 | immediate early response 2 |
|
affects expression | ISO | 19 | 25,159,276 | 25,160,800 | RGD:6480464 | CTD | |
| G | Ier3 | immediate early response 3 |
|
affects expression | ISO | 20 | 3,076,568 | 3,077,772 | RGD:6480464 | CTD | |
| G | Ier3 | immediate early response 3 |
|
decreases expression | ISO | 20 | 3,076,568 | 3,077,772 | RGD:6480464 | CTD | |
| G | Ier3 | immediate early response 3 |
|
increases expression | ISO | 20 | 3,076,568 | 3,077,772 | RGD:6480464 | CTD | |
| G | Ier5 | immediate early response 5 |
|
affects expression | ISO | 13 | 70,058,818 | 70,060,910 | RGD:6480464 | CTD | |
| G | Ifi27 | interferon, alpha-inducible protein 27 |
|
affects expression | ISO | 6 | 127,725,194 | 127,731,665 | RGD:6480464 | CTD | |
| G | Ifit1 | interferon-induced protein with tetratricopeptide repeats 1 |
|
affects expression | ISO | 1 | 238,609,171 | 238,611,236 | RGD:6480464 | CTD | |
| G | Ifitm1 | interferon induced transmembrane protein 1 |
|
affects expression | ISO | 1 | 201,154,494 | 201,155,509 | RGD:6480464 | CTD | |
| G | Ifitm3 | interferon induced transmembrane protein 3 |
|
increases expression | ISO | 1 | 201,198,659 | 201,199,768 | RGD:6480464 | CTD | |
| G | Ifnb1 | interferon beta 1, fibroblast |
|
increases expression | ISO | 5 | 107,837,628 | 107,838,182 | RGD:6480464 | CTD | |
| G | Ifng | interferon gamma |
|
multiple interactions | ISO | 7 | 57,621,756 | 57,625,792 | RGD:6480464 | CTD | |
| G | Ifng | interferon gamma |
|
multiple interactions | ISO | 7 | 57,621,756 | 57,625,792 | RGD:6480464 | CTD | |
| G | Ifng | interferon gamma |
|
multiple interactions | EXP | 7 | 57,621,756 | 57,625,792 | RGD:6480464 | CTD | |
| G | Ifngr1 | interferon gamma receptor 1 |
|
affects expression | ISO | 1 | 14,846,369 | 14,864,804 | RGD:6480464 | CTD | |
| G | Ifrd1 | interferon-related developmental regulator 1 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Igf1r | insulin-like growth factor 1 receptor |
|
decreases response to substance | ISO | 1 | 122,704,976 | 122,990,007 | RGD:6480464 | CTD | |
| G | Igfbp1 | insulin-like growth factor binding protein 1 |
|
multiple interactions | EXP | 14 | 87,950,222 | 87,955,289 | RGD:6480464 | CTD | |
| G | Igfbp5 | insulin-like growth factor binding protein 5 |
|
increases expression | ISO | 9 | 72,003,637 | 72,016,263 | RGD:6480464 | CTD | |
| G | Igflr1 | IGF-like family receptor 1 |
|
affects expression | ISO | 1 | 85,611,299 | 85,613,177 | RGD:6480464 | CTD | |
| G | Ik | IK cytokine, down-regulator of HLA II |
|
affects expression | ISO | 18 | 29,444,004 | 29,458,808 | RGD:6480464 | CTD | |
| G | Ikbkb | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
affects response to substance | ISO | 16 | 73,804,730 | 73,858,510 | RGD:6480464 | CTD | |
| G | Ikbke | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon |
|
affects expression | ISO | 13 | 44,197,625 | 44,222,609 | RGD:6480464 | CTD | |
| G | Impad1 | inositol monophosphatase domain containing 1 |
|
affects expression | ISO | 5 | 18,086,121 | 18,109,691 | RGD:6480464 | CTD | |
| G | Ing5 | inhibitor of growth family, member 5 |
|
affects expression | ISO | 9 | 93,076,701 | 93,094,002 | RGD:6480464 | CTD | |
| G | Inhbb | inhibin beta-B |
|
increases expression | ISO | 13 | 32,170,987 | 32,176,689 | RGD:6480464 | CTD | |
| G | Ins1 | insulin 1 |
|
multiple interactions | EXP | 1 | 258,001,134 | 258,001,688 | RGD:6480464 | CTD | |
| G | Insig1 | insulin induced gene 1 |
|
multiple interactions | ISO | 4 | 2,577,468 | 2,585,682 | RGD:6480464 | CTD | |
| G | Ints10 | integrator complex subunit 10 |
|
affects expression | ISO | 16 | 21,907,203 | 21,938,144 | RGD:6480464 | CTD | |
| G | Ints2 | integrator complex subunit 2 |
|
affects expression | ISO | 10 | 74,462,429 | 74,485,977 | RGD:6480464 | CTD | |
| G | Ipo4 | importin 4 |
|
affects expression | ISO | 15 | 33,761,275 | 33,771,195 | RGD:6480464 | CTD | |
| G | Ipo5 | importin 5 |
|
affects expression | ISO | 15 | 105,944,155 | 106,021,407 | RGD:6480464 | CTD | |
| G | Ipo7 | importin 7 |
|
affects expression | ISO | 1 | 167,658,312 | 167,698,113 | RGD:6480464 | CTD | |
| G | Irak1 | interleukin-1 receptor-associated kinase 1 |
|
affects expression | ISO | X | 159,960,184 | 159,969,180 | RGD:6480464 | CTD | |
| G | Irf5 | interferon regulatory factor 5 |
|
affects expression | ISO | 4 | 56,407,560 | 56,418,694 | RGD:6480464 | CTD | |
| G | Itga3 | integrin, alpha 3 |
|
decreases expression | ISO | 10 | 83,728,710 | 83,759,576 | RGD:6480464 | CTD | |
| G | Itga5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
|
decreases expression | ISO | 7 | 142,254,256 | 142,277,464 | RGD:6480464 | CTD | |
| G | Itga6 | integrin, alpha 6 |
|
affects expression | ISO | 3 | 54,202,931 | 54,272,803 | RGD:6480464 | CTD | |
| G | Itga7 | integrin, alpha 7 |
|
decreases expression | ISO | 7 | 2,230,747 | 2,269,403 | RGD:6480464 | CTD | |
| G | Itgal | integrin, alpha L |
|
decreases expression | ISO | 1 | 186,561,795 | 186,598,908 | RGD:6480464 | CTD | |
| G | Itgam | integrin, alpha M |
|
multiple interactions | ISO | 1 | 187,334,413 | 187,385,583 | RGD:6480464 | CTD | |
| G | Itgav | integrin, alpha V |
|
decreases expression | ISO | 3 | 66,953,403 | 67,029,774 | RGD:6480464 | CTD | |
| G | Itgb1 | integrin, beta 1 |
|
affects expression | ISO | 19 | 58,600,095 | 58,647,531 | RGD:6480464 | CTD | |
| G | Itgb1 | integrin, beta 1 |
|
decreases expression | ISO | 19 | 58,600,095 | 58,647,531 | RGD:6480464 | CTD | |
| G | Itgb4 | integrin, beta 4 |
|
decreases expression | ISO | 10 | 106,080,452 | 106,116,632 | RGD:6480464 | CTD | |
| G | Itgb5 | integrin, beta 5 | decreases expression | ISO | RGD:6480464 | CTD | |||||
| G | Itgb6 | integrin, beta 6 |
|
decreases expression | ISO | 3 | 42,286,140 | 42,360,793 | RGD:6480464 | CTD | |
| G | Itln1 | intelectin 1 (galactofuranose binding) |
|
affects expression | ISO | 13 | 87,445,119 | 87,455,226 | RGD:6480464 | CTD | |
| G | Itpr3 | inositol 1,4,5-trisphosphate receptor, type 3 |
|
affects expression | ISO | 20 | 5,292,430 | 5,357,502 | RGD:6480464 | CTD | |
| G | Kcnq5 | potassium voltage-gated channel, KQT-like subfamily, member 5 |
|
affects expression | ISO | 9 | 20,181,402 | 20,767,644 | RGD:6480464 | CTD | |
| G | Kdm4b | lysine (K)-specific demethylase 4B | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Kdm5a | lysine (K)-specific demethylase 5A |
|
affects expression | ISO | 4 | 156,736,343 | 156,811,991 | RGD:6480464 | CTD | |
| G | Klhl5 | kelch-like family member 5 |
|
affects expression | ISO | 14 | 45,846,061 | 45,886,040 | RGD:6480464 | CTD | |
| G | Lbh | limb bud and heart development |
|
affects expression | ISO | 6 | 22,662,376 | 22,664,667 | RGD:6480464 | CTD | |
| G | LOC100151767 | hypothetical LOC100151767 |
|
affects expression | ISO | 8 | 53,966,678 | 53,977,137 | RGD:6480464 | CTD | |
| G | LOC100360056 | 6.8 kDa mitochondrial proteolipid |
|
decreases expression | ISO | 1 | 172,267,931 | 172,268,661 | RGD:6480464 | CTD | |
| G | LOC100360497 | G protein-coupled receptor 114-like |
|
increases expression | ISO | 19 | 10,517,112 | 10,539,070 | RGD:6480464 | CTD | |
| G | LOC100360940 | diablo-like |
|
multiple interactions | EXP | 5 | 148,562,065 | 148,563,619 | RGD:6480464 | CTD | |
| G | LOC100360940 | diablo-like |
|
increases secretion | EXP | 5 | 148,562,065 | 148,563,619 | RGD:6480464 | CTD | |
| G | LOC100361295 | methylmalonyl-Coenzyme A mutase |
|
affects expression | ISO | 9 | 15,768,911 | 15,797,489 | RGD:6480464 | CTD | |
| G | LOC100361913 | rCG54286-like |
|
affects expression | ISO | 1 | 84,383,795 | 84,384,760 | RGD:6480464 | CTD | |
| G | LOC498222 | similar to specifically androgen-regulated protein |
|
affects expression | ISO | 13 | 43,666,569 | 43,679,410 | RGD:6480464 | CTD | |
| G | LOC500354 | similar to C030030A07Rik protein |
|
affects expression | ISO | 4 | 173,862,352 | 173,874,481 | RGD:6480464 | CTD | |
| G | LOC502894 | hypothetical protein LOC502894 |
|
affects expression | ISO | 4 | 163,481,393 | 163,502,412 | RGD:6480464 | CTD | |
| G | LOC681292 | hypothetical protein LOC681292 |
|
decreases expression | ISO | 3 | 120,453,601 | 120,537,113 | RGD:6480464 | CTD | |
| G | LOC689959 | hypothetical protein LOC689959 |
|
affects expression | ISO | 8 | 54,093,696 | 54,100,678 | RGD:6480464 | CTD | |
| G | Map3k5 | mitogen-activated protein kinase kinase kinase 5 |
|
increases activity | EXP | 1 | 15,205,361 | 15,346,422 | RGD:6480464 | CTD | |
| G | Map3k5 | mitogen-activated protein kinase kinase kinase 5 |
|
increases expression | EXP | 1 | 15,205,361 | 15,346,422 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | EXP | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
increases phosphorylation | EXP | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | EXP | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | EXP | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | EXP | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
increases phosphorylation | EXP | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk7 | mitogen-activated protein kinase 7 |
|
multiple interactions | ISO | 10 | 47,649,203 | 47,654,316 | RGD:6480464 | CTD | |
| G | Mfsd12 | major facilitator superfamily domain containing 12 |
|
affects expression | ISO | 7 | 9,831,853 | 9,838,324 | RGD:6480464 | CTD | |
| G | MGC94335 | similar to hypothetical protein FLJ22555 |
|
affects expression | ISO | 9 | 56,302,284 | 56,310,215 | RGD:6480464 | CTD | |
| G | Mpc2 | mitochondrial pyruvate carrier 2 |
|
affects expression | ISO | 13 | 81,184,656 | 81,203,905 | RGD:6480464 | CTD | |
| G | Msh6 | mutS homolog 6 (E. coli) |
|
affects expression | ISO | 6 | 11,525,292 | 11,542,592 | RGD:6480464 | CTD | |
| G | Mt-co2 | mitochondrially encoded cytochrome c oxidase II |
|
multiple interactions | ISO | MT | 7,006 | 7,689 | RGD:6480464 | CTD | |
| G | Mt-co2 | mitochondrially encoded cytochrome c oxidase II |
|
increases expression | ISO | MT | 7,006 | 7,689 | RGD:6480464 | CTD | |
| G | Mt1a | metallothionein 1a |
|
multiple interactions | ISO | 19 | 11,261,631 | 11,262,647 | RGD:6480464 | CTD | |
| G | Mt1a | metallothionein 1a |
|
increases expression | ISO | 19 | 11,261,631 | 11,262,647 | RGD:6480464 | CTD | |
| G | Mta3 | metastasis associated 1 family, member 3 |
|
affects expression | ISO | 6 6 |
7,060,212 7,060,212 |
7,180,405 7,180,405 |
RGD:6480464 | CTD | |
| G | Mtf1 | metal-regulatory transcription factor 1 |
|
multiple interactions | ISO | 5 | 144,135,674 | 144,180,430 | RGD:6480464 | CTD | |
| G | Nat10 | N-acetyltransferase 10 (GCN5-related) |
|
affects expression | ISO | 3 | 89,015,613 | 89,054,370 | RGD:6480464 | CTD | |
| G | Nav2 | neuron navigator 2 |
|
affects expression | ISO | 1 | 99,041,044 | 99,410,077 | RGD:6480464 | CTD | |
| G | Nceh1 | neutral cholesterol ester hydrolase 1 |
|
affects expression | ISO | 2 | 113,069,474 | 113,128,268 | RGD:6480464 | CTD | |
| G | Nceh1 | neutral cholesterol ester hydrolase 1 |
|
affects expression | ISO | 2 | 113,069,474 | 113,128,268 | RGD:6480464 | CTD | |
| G | Nfe2l2 | nuclear factor, erythroid derived 2, like 2 |
|
increases localization | ISO | 3 | 58,366,693 | 58,394,116 | RGD:6480464 | CTD | |
| G | Nmd3 | NMD3 homolog (S. cerevisiae) |
|
increases expression | ISO | 2 | 159,851,267 | 159,876,465 | RGD:6480464 | CTD | |
| G | Nos3 | nitric oxide synthase 3, endothelial cell |
|
multiple interactions | ISO | 4 | 6,158,847 | 6,179,441 | RGD:6480464 | CTD | |
| G | Nos3 | nitric oxide synthase 3, endothelial cell |
|
decreases expression | ISO | 4 | 6,158,847 | 6,179,441 | RGD:6480464 | CTD | |
| G | Ntn4 | netrin 4 |
|
affects expression | ISO | 7 | 30,717,988 | 30,832,378 | RGD:6480464 | CTD | |
| G | Ocel1 | occludin/ELL domain containing 1 |
|
affects expression | ISO | 16 | 18,532,477 | 18,534,246 | RGD:6480464 | CTD | |
| G | Ociad2 | OCIA domain containing 2 |
|
affects expression | ISO | 14 | 37,273,819 | 37,292,695 | RGD:6480464 | CTD | |
| G | Olr484 | olfactory receptor 484 |
|
affects expression | ISO | 3 | 69,378,937 | 69,379,884 | RGD:6480464 | CTD | |
| G | Parpbp | PARP1 binding protein |
|
affects expression | ISO | 7 | 24,777,634 | 24,847,083 | RGD:6480464 | CTD | |
| G | Pbld2 | phenazine biosynthesis-like protein domain containing 2 |
|
decreases expression | ISO | 20 | 25,379,865 | 25,410,260 | RGD:6480464 | CTD | |
| G | Pbld2 | phenazine biosynthesis-like protein domain containing 2 |
|
affects expression | ISO | 20 | 25,379,865 | 25,410,260 | RGD:6480464 | CTD | |
| G | Phf6 | PHD finger protein 6 |
|
increases expression | ISO | X | 139,850,136 | 139,890,670 | RGD:6480464 | CTD | |
| G | Pigz | phosphatidylinositol glycan anchor biosynthesis, class Z |
|
affects expression | ISO | 11 | 70,653,993 | 70,673,626 | RGD:6480464 | CTD | |
| G | Plekha5 | pleckstrin homology domain containing, family A member 5 |
|
affects expression | ISO | 4 | 177,616,038 | 177,784,751 | RGD:6480464 | CTD | |
| G | Ppp1r13l | protein phosphatase 1, regulatory subunit 13 like |
|
affects expression | ISO | 1 | 78,727,071 | 78,896,831 | RGD:6480464 | CTD | |
| G | Prdx1 | peroxiredoxin 1 |
|
multiple interactions | ISO | 5 | 136,975,780 | 136,991,630 | RGD:6480464 | CTD | |
| G | Prdx1l1 | peroxiredoxin 1-like 1 |
|
affects expression | ISO | 2 | 201,373,420 | 201,374,019 | RGD:6480464 | CTD | |
| G | Prdx1l1 | peroxiredoxin 1-like 1 |
|
decreases response to substance | ISO | 2 | 201,373,420 | 201,374,019 | RGD:6480464 | CTD | |
| G | Prdx1l1 | peroxiredoxin 1-like 1 |
|
multiple interactions | ISO | 2 | 201,373,420 | 201,374,019 | RGD:6480464 | CTD | |
| G | Prdx1l1 | peroxiredoxin 1-like 1 |
|
increases expression | ISO | 2 | 201,373,420 | 201,374,019 | RGD:6480464 | CTD | |
| G | Prrt2 | proline-rich transmembrane protein 2 |
|
affects expression | ISO | 1 | 186,196,585 | 186,199,258 | RGD:6480464 | CTD | |
| G | Psca | prostate stem cell antigen |
|
affects expression | ISO | 7 | 112,823,862 | 112,835,190 | RGD:6480464 | CTD | |
| G | Ptgs2 | prostaglandin-endoperoxide synthase 2 |
|
increases activity | ISO | 13 | 64,427,288 | 64,432,978 | RGD:6480464 | CTD | |
| G | Ptgs2 | prostaglandin-endoperoxide synthase 2 |
|
multiple interactions | ISO | 13 | 64,427,288 | 64,432,978 | RGD:6480464 | CTD | |
| G | Rbbp6 | retinoblastoma binding protein 6 |
|
affects expression | ISO | 1 | 181,818,248 | 181,849,942 | RGD:6480464 | CTD | |
| G | Rc3h1 | ring finger and CCCH-type domains 1 |
|
multiple interactions | ISO | 13 | 76,493,343 | 76,530,107 | RGD:6480464 | CTD | |
| G | Relb | v-rel reticuloendotheliosis viral oncogene homolog B | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Relb | v-rel reticuloendotheliosis viral oncogene homolog B | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | RGD1305235 | similar to RIKEN cDNA 1700052N19 |
|
affects expression | ISO | 1 | 35,143,718 | 35,169,030 | RGD:6480464 | CTD | |
| G | RGD1307461 | similar to RIKEN cDNA 6430571L13 gene; similar to g20 protein |
|
affects expression | ISO | 8 | 112,581,375 | 112,591,068 | RGD:6480464 | CTD | |
| G | RGD1307704 | similar to RIKEN cDNA 2410016O06 |
|
affects expression | ISO | 6 | 107,985,351 | 107,987,969 | RGD:6480464 | CTD | |
| G | RGD1307752 | similar to RIKEN cDNA 1110008F13 |
|
affects expression | ISO | 3 | 147,266,788 | 147,276,798 | RGD:6480464 | CTD | |
| G | RGD1310257 | similar to RIKEN cDNA 6330408A02 gene |
|
affects expression | ISO | 1 | 73,708,507 | 73,728,764 | RGD:6480464 | CTD | |
| G | RGD1310769 | similar to HSPC288 |
|
affects expression | ISO | 6 | 109,934,787 | 109,945,923 | RGD:6480464 | CTD | |
| G | RGD1311648 | similar to hypothetical protein FLJ21820 |
|
affects expression | ISO | 6 | 31,758,976 | 31,845,613 | RGD:6480464 | CTD | |
| G | RGD1311892 | similar to hypothetical protein FLJ10901 |
|
affects expression | ISO | 13 | 49,249,247 | 49,269,528 | RGD:6480464 | CTD | |
| G | RGD1562218 | similar to RIKEN cDNA 0610039J04 |
|
affects expression | ISO | 19 | 55,019,196 | 55,033,524 | RGD:6480464 | CTD | |
| G | RGD1563482 | similar to hypothetical protein FLJ38663 |
|
affects expression | ISO | 12 | 33,377,684 | 33,391,371 | RGD:6480464 | CTD | |
| G | RGD1563866 | RGD1563866 |
|
affects expression | ISO | 8 | 54,601,616 | 54,606,203 | RGD:6480464 | CTD | |
| G | RGD1564036 | similar to RIKEN cDNA 3010026O09 |
|
affects expression | ISO | 10 | 35,724,312 | 35,751,257 | RGD:6480464 | CTD | |
| G | RGD1564420 | similar to Hypothetical protein MGC31278 |
|
affects expression | ISO | 7 | 96,112,349 | 96,169,399 | RGD:6480464 | CTD | |
| G | RGD1564450 | RGD1564450 |
|
affects expression | ISO | 20 | 5,773,534 | 5,775,502 | RGD:6480464 | CTD | |
| G | RGD1565059 | similar to hypothetical protein E130311K13 |
|
affects expression | ISO | 2 | 153,709,289 | 153,733,281 | RGD:6480464 | CTD | |
| G | RGD1565222 | similar to RIKEN cDNA 4931414P19 |
|
affects expression | ISO | 15 | 32,656,277 | 32,688,050 | RGD:6480464 | CTD | |
| G | Rimkla | ribosomal modification protein rimK-like family member A |
|
affects expression | ISO | 5 | 140,060,901 | 140,085,824 | RGD:6480464 | CTD | |
| G | Rint1 | RAD50 interactor 1 |
|
affects expression | ISO | 4 | 6,691,863 | 6,728,969 | RGD:6480464 | CTD | |
| G | Rmdn2 | regulator of microtubule dynamics 2 |
|
affects expression | ISO | 6 | 2,440,492 | 2,514,419 | RGD:6480464 | CTD | |
| G | Rmi2 | RMI2, RecQ mediated genome instability 2, homolog (S. cerevisiae) |
|
affects expression | ISO | 10 | 4,765,965 | 4,771,062 | RGD:6480464 | CTD | |
| G | Rnf26 | ring finger protein 26 |
|
affects expression | ISO | 8 | 47,092,910 | 47,095,108 | RGD:6480464 | CTD | |
| G | RT1-CE7 | RT1 class I, locus CE7 |
|
decreases expression | ISO | 20 | 3,410,094 | 3,413,041 | RGD:6480464 | CTD | |
| G | Sepn1 | selenoprotein N, 1 |
|
affects expression | ISO | 5 | 153,295,598 | 153,308,305 | RGD:6480464 | CTD | |
| G | Slc18b1 | solute carrier family 18, subfamily B, member 1 |
|
affects expression | ISO | 1 | 22,201,424 | 22,255,955 | RGD:6480464 | CTD | |
| G | Sod1 | superoxide dismutase 1, soluble |
|
decreases activity | ISO | 11 | 29,810,766 | 29,816,342 | RGD:6480464 | CTD | |
| G | Sp1 | Sp1 transcription factor |
|
multiple interactions | ISO | 7 | 141,164,180 | 141,194,509 | RGD:6480464 | CTD | |
| G | Spag4 | sperm associated antigen 4 |
|
affects expression | ISO | 3 | 146,472,609 | 146,476,953 | RGD:6480464 | CTD | |
| G | Spint2 | serine peptidase inhibitor, Kunitz type, 2 |
|
decreases expression | ISO | 1 | 84,393,845 | 84,416,299 | RGD:6480464 | CTD | |
| G | Sqrdl | sulfide quinone reductase-like (yeast) |
|
affects expression | ISO | 3 | 109,743,347 | 109,752,321 | RGD:6480464 | CTD | |
| G | Sqrdl | sulfide quinone reductase-like (yeast) |
|
increases expression | ISO | 3 | 109,743,347 | 109,752,321 | RGD:6480464 | CTD | |
| G | Stab1 | stabilin 1 |
|
decreases expression | ISO | 16 | 6,567,583 | 6,597,972 | RGD:6480464 | CTD | |
| G | Timd4 | T-cell immunoglobulin and mucin domain containing 4 |
|
affects expression | ISO | 10 | 31,892,078 | 31,927,581 | RGD:6480464 | CTD | |
| G | Tmem65 | transmembrane protein 65 |
|
decreases expression | ISO | 7 | 95,545,429 | 95,587,199 | RGD:6480464 | CTD | |
| G | Trappc13 | trafficking protein particle complex 13 |
|
affects expression | ISO | 2 | 35,069,282 | 35,100,637 | RGD:6480464 | CTD | |
| G | Trex1 | three prime repair exonuclease 1 |
|
increases expression | ISO | 8 | 114,071,508 | 114,072,509 | RGD:6480464 | CTD | |
| G | Trim2 | tripartite motif-containing 2 |
|
affects expression | ISO | 2 | 175,908,880 | 175,974,709 | RGD:6480464 | CTD | |
| G | Trim6 | tripartite motif containing 6 |
|
affects expression | ISO | 1 | 162,059,220 | 162,094,672 | RGD:6480464 | CTD | |
| G | Trmt6 | tRNA methyltransferase 6 homolog (S. cerevisiae) |
|
affects expression | ISO | 3 | 120,602,570 | 120,614,291 | RGD:6480464 | CTD | |
| G | Ttc3 | tetratricopeptide repeat domain 3 |
|
multiple interactions | ISO | 11 | 34,617,072 | 34,659,043 | RGD:6480464 | CTD | |
| G | Ttc3 | tetratricopeptide repeat domain 3 |
|
increases expression | ISO | 11 | 34,617,072 | 34,659,043 | RGD:6480464 | CTD | |
| G | Tuba1b | tubulin, alpha 1B |
|
multiple interactions | ISO | 7 | 137,706,858 | 137,709,839 | RGD:6480464 | CTD | |
| G | Tuba1b | tubulin, alpha 1B |
|
decreases expression | ISO | 7 | 137,706,858 | 137,709,839 | RGD:6480464 | CTD | |
| G | Ube2h | ubiquitin-conjugating enzyme E2H |
|
affects expression | ISO | 4 | 57,121,159 | 57,216,956 | RGD:6480464 | CTD | |
| G | Vegfa | vascular endothelial growth factor A |
|
multiple interactions | ISO | 9 | 10,520,730 | 10,536,071 | RGD:6480464 | CTD | |
| G | Vegfa | vascular endothelial growth factor A |
|
increases expression | ISO | 9 | 10,520,730 | 10,536,071 | RGD:6480464 | CTD | |
| G | Vegfa | vascular endothelial growth factor A |
|
increases expression | ISO | 9 | 10,520,730 | 10,536,071 | RGD:6480464 | CTD | |
| G | Wtap | Wilms tumor 1 associated protein |
|
multiple interactions | ISO | 1 | 41,891,437 | 41,917,254 | RGD:6480464 | CTD | |
| G | XAF1 | XIAP associated factor-1 |
|
increases response to substance | ISO | 10 | 59,185,150 | 59,196,549 | RGD:6480464 | CTD | |
| G | Zfp395 | zinc finger protein 395 |
|
affects expression | ISO | 15 | 44,806,300 | 44,819,787 | RGD:6480464 | CTD | |
| G | Zfp867 | zinc finger protein 867 |
|
affects expression | ISO | 10 | 45,764,849 | 45,775,258 | RGD:6480464 | CTD | |




browse the term